Identification and characterization of differentially expressed microRNAs in adult tissues of the long-lived Drosophila dilp2-3,5 mutant by Werner, Jennifer Annette
 
 
 
 
Identification and characterization of differentially expressed microRNAs 
in adult tissues of the long-lived Drosophila dilp2-3,5 mutant 
 
 
 
 
 
I n a u g u r a l - D i s s e r t a t i o n 
 
 
 
zur 
 
 
 
Erlangung des Doktorgrades 
 
 
 
der Mathematisch-Naturwissenschaftlichen Fakultät 
 
 
 
der Universität zu Köln 
 
 
 
vorgelegt von 
 
 
 
Jennifer Annette Werner 
 
 
 
aus Leverkusen 
 
 
 
 
 
 
Berichterstatter:   Prof. Dr. Linda Partridge 
 
 
     Prof. Dr. Thorsten Hoppe 
 
 
 
 
 
Tag der mündlichen Prüfung: 07.03.2014 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dedicated to my beloved mother. 
18/6/1958 – 08/1/2013 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acknowledgements 
I am grateful to Linda Partridge for her supervision, invaluable help and advice during the 
course of my PhD and foremost for providing me with the opportunity to work as a part of her 
research group.  
Thanks also go to Sebastian Grönke for excellent mentorship throughout the PhD.  
I am also indebted to Eric Lai for the genetic tools used in this study and the fruitful 
discussion when we met on the conference in Washington. 
I appreciate the cooperation and assistance from the bioinformatic facility, especially 
Christoph Dieterich and Corinna Klein.  
Big thanks to Bruno Hüttel who did the sequencing no matter how small the input material 
was.  
I would like to thank all people from the Partridge lab, past and present, for their friendship 
and who made the time so enjoyable. In particular, I will remember all the get-togethers and 
the coffee breaks in Petit Noir with Marianna Gorsky and Sunita Afschar. Thanks also go to 
the technicians, not only for technical assistance, but also for the wonderful atmosphere in the 
lab. 
I want to thank Stephan Dietz for his support, encouraging words and foremost for his endless 
love. 
Finally, I want to thank my friends, my father Christian, my mother Elisabeth of blessed 
memory, my brothers Daniel, Andreas and Arthur for tracking the course of my PhD with 
interest and supporting me with love, good food and magic. 
 
 
 
 
 
 
Table of contents 
 
I 
 
Table of contents 
Abbreviations ........................................................................................................................................ V 
Kurzzusammenfassung .................................................................................................................... VIII 
Abstract ................................................................................................................................................ IX 
1 Introduction ........................................................................................................................................ 1 
1.1 MicroRNAs .................................................................................................................................... 1 
1.2 MicroRNA-mediated gene silencing and origin of microRNAs ..................................................... 1 
1.3 Evolutionarily conservation of microRNAs and their mRNA targets ............................................ 2 
1.4 Genomic arrangement of microRNAs and their control of transcription...................................... 2 
1.5 MicroRNA biogenesis pathway ..................................................................................................... 3 
1.6 MicroRNA functions in Drosophila ............................................................................................... 4 
1.7 MicroRNAs and aging ................................................................................................................... 5 
1.8 The IIS pathway extends lifespan in diverse organisms ................................................................ 5 
1.9 MicroRNAs regulate the activity of the IIS pathway ..................................................................... 6 
1.10 MicroRNAs and the regulation of IIS dependent lifespan extension ........................................... 7 
1.11 Aims of the project ....................................................................................................................... 8 
2 Results ................................................................................................................................................. 9 
2.1 Tissue-specific microRNA expression profiling using microarrays ............................................ 10 
2.1.1 Pre-test - Identification of differentially expressed microRNAs in thoraces of dilp2-3,5 
mutants .......................................................................................................................................... 10 
2.1.2 Drosophila tissues have characteristic microRNA expression profiles ............................... 11 
2.1.3 Identification of tissue-specific microRNAs by microarray ................................................. 12 
2.1.4 Evolutionary conservation of microRNAs does not correlate with expression level as 
detected by microarray .................................................................................................................. 14 
2.1.5 Expression level as detected by microarray does not correlate with tissue specificity ........ 14 
2.1.6 Identification of differentially expressed microRNAs in four tissues of dilp2-3,5 mutants . 16 
2.1.7 MicroRNA expression in the thorax as detected by microarray is reproducible .................. 18 
2.1.7.1 Verification of differentially expressed microRNAs in independent thorax 
samples......................................................................................................................................18 
2.1.7.2 Verification of differentially expressed microRNAs by quantitative RT-PCR ............. 20 
2.2 Functional in vivo characterization of differentially expressed microRNAs............................... 22 
2.2.1 Organismal growth and development time of flies overexpressing microRNAs ................. 23 
2.2.2 Lifespan and fecundity of strongly ubiquitously overexpressed microRNAs ...................... 25 
2.2.3 Lifespan of mildly ubiquitously overexpressed microRNAs ............................................... 27 
2.2.4 Lifespan analysis upon tissue-specific overexpression of microRNAs ................................ 30 
2.3 The Drosophila miR-986 knock-out mutant ................................................................................ 32 
2.3.1 Generation of a Drosophila miR-986 knock-out mutant ...................................................... 32 
2.3.2 In vivo characterization of miR-986
KO 
mutants ..................................................................... 33 
Table of contents 
 
II 
 
2.3.3 Putative targets of miR-986 .................................................................................................. 37 
2.4 Next-generation sequencing of Drosophila tissues ..................................................................... 38 
2.4.1 Establishment of a small RNA preparation protocol for deep sequencing of Drosophila 
microRNAs .................................................................................................................................... 38 
2.4.1.1 Standard microRNA library generation resulted in ribosomal RNA contamination ..... 38 
2.4.1.2 Optimization of microRNA library preparation ............................................................ 39 
2.4.2 Next generation sequencing of Drosophila tissues .............................................................. 41 
2.4.3 Identification of non-microRNA reads ................................................................................. 44 
2.4.4 Tissue-specific microRNA expression profiles .................................................................... 44 
2.4.5 Identification of tissue-specific microRNAs by sequencing ................................................ 45 
2.4.6 Evolutionary conservation of microRNAs correlates with expression level as detected by 
sequencing ..................................................................................................................................... 47 
2.4.7 Expression level as detected by sequencing does not correlate with tissue specificity ........ 47 
2.4.8 Identification of differentially expressed microRNAs in dilp2-3,5 tissues by sequencing .. 49 
2.4.9 qRT-PCR analysis of differential expressed microRNAs .................................................... 51 
2.5 Comparison of microarray with next-generation sequencing data ............................................. 52 
2.5.1 Comparison of absolute expression datasets between next-generation sequencing and 
microarrays .................................................................................................................................... 52 
2.5.2 Analyzed microRNAs have different calculated hybridization affinities to microarray 
chips................................................................................................................................................54 
2.5.3 Comparison of differential expression datasets between sequencing and microarrays ........ 54 
2.5.4 Correlation between expression level and fold change in differentially expressed 
microRNAs .................................................................................................................................... 56 
3 Discussion .......................................................................................................................................... 58 
3.1 Next generation sequencing of Drosophila tissues...................................................................... 58 
3.2 Comparison of absolute expression datasets between sequencing and microarrays .................. 59 
3.3 Adult Drosophila microRNA expression atlas ............................................................................ 61 
3.3.1 Tissue-specific microRNA expression profiles .................................................................... 61 
3.3.2 Tissue specificity of microRNAs is in agreement with published data ................................ 61 
3.3.3 Strong microRNA expression increases reliability in the detection of tissue-specificity ..... 63 
3.3.4 Evolutionary conservation of microRNAs does not correlate with breadth of expression .. 63 
3.3.5 Evolutionary conservation of microRNAs correlates with expression level ........................ 63 
3.4 Differentially expressed microRNAs in dilp2-3,5 mutants .......................................................... 64 
3.4.1 MicroRNA candidates and their role in regulation of lifespan ............................................. 65 
3.4.2 The microRNA 6~309 cluster is up-regulated in dilp2-3,5 abdomen .................................. 68 
3.5 The miR-986
KO
 mutant ................................................................................................................. 68 
3.6 Functional characterization of differentially expressed microRNAs by overexpression ............ 69 
4 Material and methods ...................................................................................................................... 72 
4.1 Bacterial media ........................................................................................................................... 72 
4.2 Solutions ...................................................................................................................................... 72 
4.3 Drosophila food media ................................................................................................................ 73 
4.4 Fly stocks, genetic background and general animal husbandry ................................................. 73 
Table of contents 
 
III 
 
4.5 Collecting males and virgins and setting up crosses ................................................................... 74 
4.6 Egg collections for experiments .................................................................................................. 74 
4.7 Mapping of transgene insertions ................................................................................................. 75 
4.8 Expression of genes with the UAS/Gal4 System .......................................................................... 75 
4.9. Fly stress assays ......................................................................................................................... 75 
4.10 Lifespan assay ........................................................................................................................... 75 
4.11 Fecundity assay ......................................................................................................................... 76 
4.12 Development time assay ............................................................................................................ 76 
4.13 Body weight ............................................................................................................................... 76 
4.14 Tissue dissection ........................................................................................................................ 76 
4.15 Mechanic separation of thoraces and heads ............................................................................. 76 
4.16 General cloning techniques and molecular biology .................................................................. 77 
4.16.1 Polymerase chain reaction (PCR) ....................................................................................... 77 
4.16.1.1 Genotyping of flies by PCR ........................................................................................ 77 
4.16.1.2 Amplification of cloning constructs ............................................................................ 77 
4.16.1.3 Quantitative real-time reverse transcription-PCR (qRT-PCR) .................................... 78 
4.16.1.3.1 qRT-PCR of miRNAs ........................................................................................... 78 
4.16.1.3.2 qRT-PCR of mRNAs ............................................................................................ 78 
4.16.2 Agarose gel electrophoresis ................................................................................................ 78 
4.16.3 Gel elution .......................................................................................................................... 79 
4.16.4 cDNA synthesis by reverse transcription of miRNAs ........................................................ 79 
4.16.5 cDNA synthesis by reverse transcription of total RNAs .................................................... 79 
4.16.6 Restriction digest ................................................................................................................ 79 
4.16.7 In-Fusion
®
 cloning .............................................................................................................. 80 
4.16.8 Transformation of chemically competent E. coli ............................................................... 80 
4.16.9 Plasmid DNA purification .................................................................................................. 80 
4.16.10 Plasmid DNA purification for generation of transgenic flies ........................................... 80 
4.16.11 Conventional Sanger sequencing of cloned constructs .................................................... 81 
4.16.12 Genomic DNA preparation from whole flies ................................................................... 81 
4.16.13 RNA extraction ................................................................................................................. 81 
4.16.14 Determination of RNA concentration............................................................................... 81 
4.16.15 Polyacrylamide RNA gel electrophoresis ......................................................................... 81 
4.16.16 RNA gel elution and precipitation .................................................................................... 82 
4.17 Generation of targeting construct and donor flies for the knock-out of miR-986 ..................... 82 
4.18 Generation of miR-986
KO 
flies ................................................................................................... 82 
4.19 Microarrays ............................................................................................................................... 83 
4.20 RNA column fractionation ......................................................................................................... 83 
4.21 rRNA depletion using magnetic beads ...................................................................................... 83 
4.22 Illumina small RNA library preparation ................................................................................... 84 
4.23 Cluster generation and sequencing ........................................................................................... 84 
4.24 Data analysis ............................................................................................................................. 85 
Table of contents 
 
IV 
 
4.24.1 Statistics .............................................................................................................................. 85 
4.24.2 Calculation of melting temperature (Tm) ........................................................................... 85 
4.24.3 Calculation of tissue specificity score ................................................................................ 85 
4.24.4 Computational miRNA target prediction ........................................................................... 85 
4.24.5 Data analysis of microarray data ........................................................................................ 85 
4.24.5.1 Preprocessing ............................................................................................................... 85 
4.24.5.2 Image analysis ............................................................................................................. 86 
4.24.5.3 Background adjustment ............................................................................................... 86 
4.24.5.4 Normalization .............................................................................................................. 86 
4.24.5.5 Summarization ............................................................................................................. 86 
4.24.5.6 Statistics ....................................................................................................................... 86 
4.24.6 Analysis of sequencing data ............................................................................................... 87 
4.24.7 Computational identification of differentially expressed miRNAs .................................... 87 
5 Supplements ...................................................................................................................................... 88 
5.1 Supplemental Figures .................................................................................................................. 88 
5.2 Supplemental Tables .................................................................................................................... 91 
Index of figures .................................................................................................................................. 101 
References .......................................................................................................................................... 103 
Erklärung ........................................................................................................................................... 112 
Lebenslauf .......................................................................................................................................... 113 
 
 
 
 
 
 
Abbreviations 
 
V 
 
Abbreviations  
Ago Argonaute protein 
bp base pairs 
C. elegans Caenorhabditis elegans 
cDNA complementary deoxyribonucleic acid 
cm centimetre 
CO2 carbon dioxide 
Cre cre recombinase 
CT controlled temperature 
Cyp4e2 bytochrome P450-4e2 
daGS daughterless-GeneSwitch 
DDT dichlorodiphenyltrichloroethane 
DEPC biethylpyrocarbonate 
DILP Drosophila insulin-like peptide 
dNTP desoxynucleosidtriphosphate 
dFOXO DrosophilaForkhead box protein 
DNA deoxyribonucleic acid 
EDTA ethylenediaminetetraacetic acid 
EtBR ethidium bromide 
EtOH ethanol 
et al. et alii 
E. coli Escherichia coli 
e.g. exempli gratia 
FC fold change 
FOXO forkhead box protein 
F1 filial 1 
g gram 
Gal4 yeast transcription activator protein Gal4 
GS GeneSwitch 
HCl hydrogen chloride 
HIF hypoxia-inducible factor 
hsp70 70 kilodalton heat shock protein 
h hour 
H2O water 
H2O2 hydrogene peroxide 
IGF insulin-like growth factor 
IGF1R insulin-like growth factor 1 receptor 
IIS insulin/IGF-like signaling 
InR insulin receptor 
InR
DN
 insulin receptor dominant negative mutant 
INSR mammalian insulin receptor 
IPCs insulin producing cells 
IRS insulin receptor substrate 
JNK c-Jun N-terminal kinase 
KCl potassium chloride 
KO knock-out 
Lnk link adaptor protein 
LB lysogeny broth 
M molar 
Abbreviations 
 
VI 
 
mA milliampere 
MgCl2 magnesium chloride 
MgSO4 magnesium sulfate 
MHC myosin heavy chain 
min minute 
ml milliliter 
mM milli molar 
mNSCs median neurosecretory cells 
miRISC micro - ribonucleic acid induced silencing complex 
miRNA microRNAs; micro ribonucleic acid 
mRNA messenger ribonucleic acid 
µg microgram 
µl microliter 
µM micromolar 
NaCl sodium chloride 
NaH2PO4 monosodium phosphate 
Na2HPO4 disodium phophate 
NaOH sodium hydroxide 
ng nanogram 
nt nucleotides 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
pH-value hydrogen ion concentration 
pM picomolar 
polyA polyadenylation 
pre-miRNA precursor micro ribonucleic acid 
piwiRNA piwi-interacting 
pri-miRNA primary micro ribonucleic acid 
PTEN phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase 
qRT-PCR quantitative real-time reverse transcription-PCR 
RISC ribonucleic acid induced silencing complex 
RNA ribonucleic acid 
RNAi ribonucleic acid interference 
RNase ribonuclease 
rpm rotations per minute 
rRNA ribosomal ribonucleic acid 
RU486 Mifepristone 
SDS sodium dodecyl sulfate 
sec seconds 
siRNA short interfering ribonucleic acid 
SIRT1/2 silent information regulator 1/2 
SSC saline-sodium citrate 
SV40 simian vacuolating virus 40 
SYA sugar yeast agar 
S6K S6 kinase 
TAE tris-acetate-EDTA-buffer 
TEMED N,N,N´,N´-tetramethylethylendiamine 
TBE tris-borate-EDTA-buffer 
Tris 2-amino-2-(hydroxymethyl)1,3-propandiol 
Tm melting temperature 
tubulinGS tubulin GeneSwitch 
Abbreviations 
 
VII 
 
U units 
UAS upstream Activation Sequence 
UV ultraviolet 
V Volume 
w
Dah
 white Dahomey 
wt wild type 
w/v weight per volume 
2nd second 
3rd third 
°C degree celsius 
 
 
 
Kurzzusammenfassung 
 
VIII 
 
Kurzzusammenfassung 
MicroRNAs sind kleine regulatorische Moleküle, welche in Eukaryoten diverse Funktionen 
durch die Steuerung der Expression von Genen auf post-transkriptioneller Ebene in 
spezifischen Geweben ausüben. In der Fruchtfliege Drosophila melanogaster sind 238 
miRNA Gene annotiert, die nur vereinzelt funktionell charakterisiert sind. Einige miRNAs 
spielen eine Rolle in biologischen Prozessen des Alterns und stehen im direkten 
Zusammenhang mit altersmodulierenden Signaltransduktionswegen, zu denen auch der 
Insulin/IGF-ähnliche Signalweg (IIS) zählt. Ob miRNAs die phänotypischen Effekte von 
reduziertem IIS, wie Lebensverlängerung und Resistenz gegenüber Stressfaktoren, vermitteln, 
ist gänzlich unbekannt. Für eine umfangreiche Charakterisierung von miRNAs ist die 
Information über gewebespezifische Expression unerlässlich. Bei der adulten Fliege wurden 
bisher nur Ovarien untersucht und es wurde zwischen der Expression in Köpfen und ganzen 
Körpern unterschieden. In der vorliegenden Arbeit wurden erstmals spezifische miRNA-
Expressionsprofile der vier folgenden adulten Gewebe erstellt; des Gehirns,  des Thorax, des 
Darmes und des Abdomens. Des Weiteren wurden in dieser Arbeit differenziell regulierte 
miRNAs in Geweben von langlebigen Drosophila dilp2-3,5-Mutanten identifiziert und mittels 
miRNA-Überexpressionsanalysen sowie einer im Rahmen dieser Arbeit generierten miRNA-
Knockout-Mutante auf IIS-assoziierte Phänotypen funktionell untersucht. Die vorliegende 
Arbeit leistet einen wesentlichen Beitrag zur Charakterisierung von miRNAs in Drosophila 
melanogaster im Allgemeinen, liefert insbesondere eine umfangreiche Analyse identifizierter 
differenziell regulierter miRNAs in langlebigen Insulin-Mutanten und trägt so zur Aufklärung 
der dem Alterungsprozess zu Grunde liegenden biologischen Mechanismen bei.  
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Abstract 
MicroRNAs are small, regulatory molecules that execute diverse functions in eukaryotes 
through the post transcriptional control of gene expression in specific tissues. In the fruit fly 
Drosophila melanogaster 238 miRNA genes are annotated and only few have been 
functionally characterized. Some miRNAs play a role in the biological processes of aging and 
are directly linked with aging-modulating pathways, including the insulin/IGF-like signaling 
(IIS) pathway. Whether miRNAs mediate phenotypic effects of reduced IIS remains 
unknown. For a comprehensive characterization of miRNA function, information about 
tissue-specific  expression is indispensible, and so far in the adult fly is limited to ovaries and 
the analysis of heads and whole bodies. In the present study for the first time miRNA 
expression profiles from four adult tissues, namely the brain, thorax, digestive tract and 
abdomen, were generated. Furthermore, differentially expressed miRNAs in tissues of the 
long-lived Drosophila dilp2-3,5 mutant were identified and functionally characterized for IIS-
associated phenotypes, by overexpression analysis and by a miRNA knock-out mutant 
generated within the scope of this study. The present study provides fundamental information 
for the characterization of miRNA function in Drosophila in general, and supplies particularly 
an analysis of identified, differentially expressed miRNAs in long-lived insulin mutants, and 
thus contributes to the elucidation of biological mechanisms underlying the process of aging. 
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1 Introduction 
1.1 MicroRNAs 
MicroRNAs (miRNAs) are a class of small non-coding regulatory RNAs that act as post-
transcriptional regulators of gene expression. Three types of small regulatory RNAs have 
been described. Short interfering RNAs (siRNAs) operate in cis by regulating the expression 
of the transcripts from which they have evolved (Katayama et al., 2005). Piwi-interacting 
RNAs (piwiRNAs) are usually expressed in germline cells and probably act as a defense 
mechanism against transposable elements and in gametogenesis (Siomi et al., 2011). MiRNAs 
act in trans by inhibiting the expression or causing the degradation of protein-coding mRNAs. 
 
1.2 MicroRNA-mediated gene silencing and origin of microRNAs 
The process of inhibiting mRNA expression by binding of complementary miRNAs or 
siRNAs is referred to as RNA interference (RNAi). Although prokaryotes have a regulatory 
system functionally analogous to RNAi (Hale et al., 2009), conventional miRNA silencing 
seems to be restricted to eukaryotes. MiRNAs are found in all multicellular eukaryotic 
organisms ranging from sponges (Grimson et al., 2008) and algae (Cock et al., 2010) to 
higher animals and plants, suggesting miRNA regulation of gene expression to be an 
evolutionary ancient mechanism. However, miRNA families are not conserved between 
plants and animals. Consistently, biogenesis (Reinhart et al., 2002), cellular localization of 
miRNA processing (Park et al., 2005; Lee et al., 2003) as well as mode of regulation (Zhang 
et al., 2007) differs between animal and plant miRNAs, suggesting that miRNAs arose 
independently in plants and animals. 
 
In plants, miRNAs probably originated by inverted duplication of protein coding genes, as the 
sequence of plant miRNAs is perfectly complementary to the sequence of their target mRNAs 
(Allen et al., 2004). In contrast, miRNAs in animals do not share high sequence similarity 
with their target genes (Nozawa et al., 2010).  However, many miRNA share sequence 
homology with transposable elements or inverted genomic repeats, suggesting that during 
evolution miRNAs may have evolved from transposable elements or inverted repeats 
(Piriyapongsa and Jordan, 2007). Within the genome miRNAs are often arranged in clusters, 
suggesting that new miRNA genes also evolved by gene duplication of already existing 
miRNAs. 
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1.3 Evolutionarily conservation of microRNAs and their mRNA targets 
Many miRNAs are highly conserved during evolution (Axtell and Bartel, 2005; Pasquinelli et 
al., 2000). However, although miRNAs can be evolutionarily conserved, their mRNA targets 
can differ between species (Chen and Rajewsky, 2006) and clade-specific changes in miRNA 
targets have been proposed to contribute to speciation and diversification of life (Grün et al., 
2005). Interestingly, the number of miRNAs present in a species is positively correlated with 
organismal complexity (Grimson et al., 2008). This finding has led to the hypothesis that  
fine-tuning of gene expression via regulation by miRNAs was necessary for the evolution of 
complex organisms (Heimberg et al., 2008). 
Although miRNA targets can change during evolution, there are several miRNAs described 
for which the mRNA targets are conserved between species. One example is the let-7 miRNA 
family. Let-7 was first described as an essential regulator of development in the nematode 
Caenorhabditis elegans and is involved in the heterochronic pathway. Heterochronic genes 
control the relative timing of events during development. Interestingly, as in C. elegans, let-7 
is both necessary and sufficient for the appropriate timing of developmental processes in the 
fruit fly Drosophila, indicating that its function as a heterochronic miRNA is evolutionarily 
conserved (Caygill and Johnston, 2008). Furthermore, targets of let-7 are conserved between 
humans and C. elegans (Chen and Rajewsky, 2006) and the expression pattern of let-7 is also 
similar between worms, flies and humans (Pasquinelli et al., 2000), suggesting that let-7 may 
regulate similar processes in these organisms. 
In general, it is suggested that conserved miRNAs are expressed at high levels and more 
broadly than non-conserved miRNAs, whereas non-conserved miRNAs often show low 
expression levels and spatial and temporal specific expression patterns (Ruby et al., 2007). 
 
1.4 Genomic arrangement of microRNAs and their control of transcription 
Consistent with the correlation of miRNA number and organismal complexity, up to now 
1872 miRNA genes are annotated in humans, 1186 in mice and 223 in C. elegans. In the 
Drosophila genome 238 miRNA genes have been identified and the number is still increasing 
(Griffiths-Jones, 2006). MiRNAs are distributed throughout the Drosophila genome and are 
located in intergenic sites, intronic sites or gene clusters (Nozawa et al., 2010) and, very 
rarely, also in exons (Berezikov et al., 2011). Approximately 50 % of Drosophila miRNAs 
are arranged in clusters with at least two or more miRNAs (Bartel, 2004). In general, 
transcription of miRNAs is regulated by their own promoter. Transcriptional regulation of 
intronic miRNAs is dependent on the orientation of the miRNA gene in relation to the protein 
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coding gene it resides in. If an intronic miRNA is arranged in antisense orientation, its 
transcription is regulated by its own promoter. In contrast, if the intronic miRNA is arranged 
in sense orientation within the protein coding gene then its transcription is more likely to be 
under the control of the promoter of the protein coding gene (Baskerville and Bartel, 2005). 
However, there are exceptions, e.g. the expression pattern of Drosophila miR-7 is distinct 
from its host gene bancal (Aboobaker et al., 2005).  
MiRNAs in gene clusters are often transcribed as entity in an operon-like manner (Ruby et al., 
2007), e.g. Drosophila mir-100, -125, and let-7 are arranged within a single cluster and were 
shown to be coup-regulated during metamorphosis. Interestingly, transcriptional regulation of 
this miRNA cluster is mediated via ecdysone and juvenile hormone. Chromosomal clustering 
of these miRNAs is evolutionarily conserved suggesting that their transcriptional regulation 
via hormones may also be conserved (Sempere et al., 2003). Transcription factors that 
regulate miRNAs expression include FOXO3a. In mammalian cells it was shown that 
FOXO3a binds to the promoter of a cluster consisting of miR-106b, miR-93, and miR-25 and 
activates its expression. Interestingly, predicted targets of miR-25 include members of the 
insulin/IGF-like signaling (IIS) pathway, suggesting that miR-25 is part of a feedback loop 
within the IIS pathway in mammals (Brett et al., 2011). Indeed, feedback loops formed by 
miRNAs and transcription factors have already been demonstrated. For example, p53 induces 
the expression of miR-34a in mammalian cells and in vivo in mice. miR-34 targets silent 
information regulator 1 (SIRT1) and SIRT1 in turn promotes p53 deacetylation and decreases 
p53 activity (Yamakuchi and Lowenstein, 2009). 
Little is known about the nature of miRNA core promoters. For in vivo analysis most studies 
define miRNA promoter regions as the genomic sequence 300-2000 bases upstream of 
miRNA genes (Martinez et al., 2008). MiRNA promoters seem to be highly similar to 
promoters of protein-coding genes (Corcoran et al., 2009). 
 
1.5 MicroRNA biogenesis pathway 
Maturation of miRNAs from a pre-miRNA transcript to the mature ~22bp long miRNA is 
controlled by the miRNA biogenesis pathway. Like protein-coding genes, miRNAs genes are 
transcribed by RNA polymerase II (Lee et al., 2004), with a few exceptions that are 
transcribed by RNA polymerase III (Borchert et al., 2006). The primary miRNA transcript 
(pri-miRNA) can be several kilobases long and can contain multiple miRNA precursors. 
Within the nucleus the pri-miRNA is recognized by Drosha, a RNase III enzyme. Together 
with the RNA binding protein DGCR8 (in Drosophila: "Pasha") Drosha cleaves the pri-
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miRNA into smaller precursor miRNAs (pre-miRNAs), which typically form stem-loop 
structures (Denli et al, 2004). The pre-miRNA is exported by Exportin-5 (Yi et al., 2003) in a 
GTP-dependent manner into the cytoplasm. There, the pre-miRNA is further cleaved by the 
RNase III enzyme Dicer (in Drosophila: "Dicer-1") (Bernstein et al., 2001). The resulting 
approximately 22 nucleotides long miRNA duplex is incorporated into the RNA induced 
silencing (RISC) complex (Hammond et al., 2000). Only one strand of the miRNA duplex is 
selected for target gene regulation while the other strand is degraded (Gregory et al., 2005). 
The final complex (miRISC) consists of the single stranded mature miRNA, Dicer, Argonaute 
(Ago) and RNA-binding proteins (in Drosophila: "loquacious"). The miRISC mediates either 
repression of translation by imperfect binding of the miRNA to the mRNA target or mRNA 
degradation by perfect complementary binding (Hutvágner and Zamore, 2002). In addition to 
cleavage by Drosha and Dicer, pri-miRNAs and pre-miRNAs can be modified by editing 
(Kawahara et al., 2007). Editing includes adenosine to inosine transitions (Kawahara et al., 
2008) or addition of nucleotides (Landgraf et al., 2007) and provides a way to regulate 
biogenesis and target specificity of miRNAs. An alternative to the canonical miRNA pathway 
is used by "mirtrons". Mirtrons are short intronic hairpins that bypass Drosha-mediated 
cleavage and enter the canonical miRNA pathway at the stage of export into the cytoplasm 
(Okamura et al., 2007). Mirtrons are a source of miRNAs and were first identified in 
Drosophila. Shortly after, it was shown that mirtrons also exist in other species including 
nematodes (Ruby et al., 2007) and mammals (Berezikov et al., 2007). 
 
1.6 MicroRNA functions in Drosophila 
The first described miRNA in Drosophila was bantam. The target of bantam is the pro-
apoptotic gene hid and it was shown, that bantam controls cell proliferation and apoptosis 
during development (Brennecke et al., 2003). Later it was shown that indeed several 
Drosophila miRNAs play roles in cell proliferation and apoptosis, including miR-2 (Leaman 
et al., 2005), miR-14 (Xu et al., 2003) and miR-278 (Nairz et al., 2006). But also muscle 
differentiation (Kwon et al., 2005), neurogenesis (Li et al., 2006), energy homeostasis 
(Teleman et al., 2006), homeotic transformation (Ronshaugen et al., 2005) and meta-
morphosis (Sempere et al., 2002) are functions that are under the control of miRNAs. 
However, assigning miRNAs to specific functions is arbitrary since one miRNA can target 
several mRNAs that play roles in different cellular functions (Lim et al., 2005). For example, 
miR-278 is not only involved in cell proliferation, but also affects energy homeostasis 
(Teleman et al., 2006). Thus, miRNAs control basic organismal functions. In doing so, 
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miRNAs are not just restricted to fine-tuning of gene expression but mutations of miRNAs 
can cause severe phenotypes. For example, loss of miR-1 causes lethality due to the 
dysfunction of muscle gene expression maintenance in flies (Kwon et al., 2005). Therefore, 
miRNAs play pivotal roles in Drosophila. 
 
1.7 MicroRNAs and aging 
MiRNAs have been implicated in the regulation of age-related diseases as well as the aging 
process itself. For example, miRNAs are differentially expressed in age-associated diseases 
like Alzheimer’s Disease (Zovoilis et al., 2011) or cancer and the expression profile of 
miRNAs is changed in tumor cells (Munker and Calin, 2011). The tumor suppressor p53 is 
known to impact aging and lifespan in worms (Derry et al., 2001), flies (Lee et al., 2003; 
Bauer et al., 2005) and mice (Lavigueur et al., 1989; Chin et al., 1999). miR-29 is expressed 
in response to DNA damage in a p53-dependent manner and is up-regulated in a mouse model 
of progeria as well as during normal aging (Ugalde et al., 2011). Indeed, in mice miRNAs 
have been suggested to be biomarkers for aging. miR-34a level increases with age while the 
level of its target SIRT1 decreases. As changes in miR-34 levels can be measured in blood, 
miR-34a expression levels are a potential biomarker for the aging process (Li et al., 2011). In 
the worm C. elegans the expression of certain miRNAs is regulated in an age-dependent 
manner (Pincus et al., 2011). Furthermore, the single miRNA lin-4 has been shown to be able 
to modulate lifespan in worms. Overexpression of lin-4 increases lifespan and its reduction 
shortens lifespan (Boehm and Slack, 2005). Since then, several other miRNAs have been 
identified that modulate lifespan in worms, including miR-71 and miR-239 (de Lencastre et 
al., 2010). Recently, also in Drosophila it has been shown that a single miRNA can regulate 
survival, since mild overexpression of miR-34 extends lifespan and mitigates induced 
neurodegeneration (Liu et al., 2012). 
 
1.8 The IIS pathway extends lifespan in diverse organisms 
The IIS pathway is an evolutionarily conserved, nutrient-responsive pathway that coordinates 
metabolic homeostasis, growth, development, stress resistance and reproduction (Broughton 
and Partridge, 2009; Toivonen and Partridge, 2009). Interestingly, decreased IIS has been 
shown to extend lifespan in organisms as diverse as worms (Kenyon et al., 1993; Lin et al., 
2001), flies (Tatar et al., 2001; Giannakou et al., 2004) and mice (Holzenberger et al., 2003; 
Selman et al., 2008). Moreover, in humans there is a correlation between longevity and 
certain alleles of the IIS downstream transcription factor FOXO3A, suggesting a conserved 
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role of IIS signaling in lifespan extension including humans (Willcox et al, 2008; Flachsbart 
et al., 2009). 
 
In the fruit fly Drosophila melanogaster several intracellular components of the IIS pathway 
have been implicated in the control of lifespan. Flies carrying hypomorphic mutations of the 
insulin receptor (InR) or mutants for the insulin receptor substrate CHICO have greatly 
extended lifespan (Tatar et al., 2001, Clancy et al., 2001). The adaptor protein Link (LNK) 
functions in parallel to CHICO (Werz et al., 2009) and Lnk mutant flies as well are long-lived 
(Slack et al., 2010). Furthermore, adult-specific overexpression of the downstream 
transcription factor dFOXO or the Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase 
(PTEN) in the fat body is sufficient to increase lifespan (Giannakou et al., 2004; Hwangbo et 
al., 2004). dFOXO has been shown to be a key downstream factor mediating the lifespan 
response to reduced IIS, since loss of dFOXO abolishes the lifespan extension of flies with 
ablated median neurosecretory cells (mNSCs) and flies expressing a dominant negative 
version of the InR (InR
DN
) (Slack et al., 2011).  
 
In addition to the intracellular IIS components, the ligands of IIS have also been implicated in 
lifespan control in flies. The Drosophila genome encodes seven insulin-like peptides (DILP1-
7). Three of the DILPs, DILP2, DILP3 and DILP5 are expressed in the mNSCs of the fly 
brain and genetic ablation of mNSCs causes increased lifespan (Broughton et al., 2005). 
Furthermore, the combined knock-out of DILP 2, 3 and 5 (dilp2-3,5 mutants) also results in 
lifespan extension. dilp2-3,5 triple mutants are not only long-lived but also show other 
characteristic phenotypes linked to reduced IIS including developmental delay, reduced body 
weight, reduced fecundity, altered metabolic homeostasis and resistance to oxidative stress 
(Grönke et al., 2010). Currently, the mechanisms why these mutants are so long-lived are not 
well understood, neither is it known whether miRNAs are involved in the regulation of 
lifespan extension or other phenotypes associated with reduced IIS. 
 
1.9 MicroRNAs regulate the activity of the IIS pathway 
There is evidence that miRNAs are involved in the regulation of IIS pathway activity. Insulin 
synthesis and secretion are both modulated by miRNAs in Drosophila. It was shown that 
miR-278 targets the mRNA of expanded, while expanded promotes dILP expression. miR-278 
mutant flies have elevated insulin production due to elevated expanded mRNA. Thus       
miR-278 controls insulin levels in flies (Teleman et al., 2006). Insulin levels are also 
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regulated by miRNAs in mammals (Poy et al., 2004, Sun et al., 2010; Melkman-Zehavi et al., 
2011). Additionally, miRNAs directly target components of the IIS pathway. Insulin-like 
growth factor 1 (IGF-1) is modulated by miRNAs in human cells (Shan et al., 2009;            
Elia et al., 2009) and in rats (Wang et al., 2009). IGF-2 (Ge et al., 2011), IGF-1 receptor, S6 
kinase (S6K) (McKinsey et al., 2011), insulin receptor substrate 1 (IRS-1) (La Rocca et al., 
2009; Karolina et al., 2011) and IRS-2 (Dávalos et al., 2011) are targeted by miRNAs in 
mammalian cells. 
 
1.10 MicroRNAs and the regulation of IIS dependent lifespan extension 
Evidence exist that miRNAs regulate IIS-dependent lifespan extension. Flies mutant for   
miR-14 are obese, have reduced insulin levels and are sensitive to starvation. miR-14 acts in 
the mNSCs by targeting the transcription factor sugarbabe, which in turn controls DILP levels 
(Varghese et al., 2010). Interestingly, miR-14 mutant flies have a reduced lifespan under 
thermal stress (Xu et al., 2003). If this is true under normal thermal conditions was not shown. 
Interestingly, in worms several miRNAs have been identified that regulate lifespan by 
modulating activity of the IIS pathway. Overexpression of lin-4 results in long-lived worms. 
The target of lin-4 is lin-14, which acts in parallel or upstream of the IIS receptor DAF-2 
(Boehm and Slack, 2005). In addition, overexpression of miR-71 increases lifespan in worms 
while overexpression of miR-239 decreases lifespan. This effect on lifespan could be 
modified by RNAi against the IIS components DAF-2 and DAF-16, suggesting that miR-71 
and miR-239 act in the IIS pathway to modulate lifespan (Pincus et al., 2011; de Lencastre    
et al., 2010). Thus, there is evidence for a crucial role of miRNAs in IIS-mediated regulation 
of lifespan in worms. However, it is currently unknown whether IIS-mediated lifespan 
extension is controlled by miRNAs in other species nor it is known whether miRNA 
expression is changed in long-lived IIS Drosophila mutants. 
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1.11 Aims of the project 
Aim 1: Generation of a Drosophila miRNA expression atlas 
For the characterization of miRNAs, information about their spatial expression is 
indispensible. So far for adult Drosophila tissues only data for heads, whole bodies and 
ovaries exist. In this study, microarrays and next-generation sequencing were used to generate 
comprehensive miRNA expression profiles of adult Drosophila tissues including brain, 
thorax, digestive tract, and abdomen.  
 
Aim 2: Identification of differentially expressed microRNAs in tissues of a long-lived 
Drosophila IIS mutant 
Whether miRNA expression is differentially regulated in IIS mutants is not known. In order to 
identify differentially expressed miRNAs in long-lived IIS mutants, next generation 
sequencing and microarrays were used to compare miRNA expression between adult tissues 
of wild type flies and long-lived dilp2-3,5 mutants.  
 
Aim 3: Functional in vivo analysis of differentially expressed microRNAs 
In order to analyze the role of miRNAs in IIS-associated phenotypes, differentially expressed 
miRNAs were functionally characterized in vivo using overexpression and knock-out fly 
lines. For one selected candidate miRNA a null mutant was generated by homologous 
recombination. To further dissect the role of miRNAs in different tissues, miRNAs were 
overexpressed tissue-specifically and analyzed for IIS-associated phenotypes. 
 
Aim 4: Comparison of microarray data with next-generation sequencing data 
Microarray and next-generation sequencing are two techniques which are used to study 
miRNA expression. Both techniques were compared for performance in the detection of 
absolute and differential expression as well as for the detection of tissue-specificity.   
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2 Results 
The downstream mechanisms of IIS related phenotypes including lifespan extension and 
stress resistance are still elusive and it is not known whether miRNAs may be involved in the 
regulation of these phenotypes. In order to investigate whether miRNAs are differentially 
expressed in tissues of long-lived Drosophila IIS mutants I used microarrays and next 
generation sequencing to compare miRNA expression profiles of wild type control flies with 
long-lived dilp2-3,5 mutant flies. Therefore, I collected brain, midgut, abdominal fat and 
muscle tissue from the thorax of 10 day old wild type control and dilp2-3,5 mutant flies 
(Figure 2.1).  
 
Figure 2.1: Project outline for the identification of differentially expressed miRNAs in tissues of adult 
Drosophila IIS mutants. 10 day old wild type and dilp2-3,5 flies were dissected, RNA was extracted 
and used for microarrays and next generation sequencing, respectively. 
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2.1 Tissue-specific microRNA expression profiling using microarrays 
2.1.1 Pre-test - Identification of differentially expressed microRNAs in thoraces of   
xdilp2-3,5 mutants 
In order to establish purification conditions for Drosophila miRNAs and to test whether 
miRNAs are differentially expressed in long-lived IIS mutants, I did a pre-test using thoraces 
of dilp2-3,5 mutants. Microarrays were used for the detection of miRNAs, because they are 
cost effective and allow fast high throughput analysis of miRNAs. For the pre-test we used 
the Affymetrix GeneChip for miRNAs 1.0, which contained probe sets for 152 mature 
Drosophila miRNAs.  
28 miRNAs were significantly changed in expression between dilp2-3,5 mutants and controls 
(summarized in Table 1). Interestingly, most differentially regulated miRNAs were up-
regulated (>80 %). However, most miRNAs showed only minor expression changes, but 14 
miRNAs had a fold change of more than 1.5 or below 0.5, respectively. mir-986-5p was the 
strongest regulated miRNA with a fold change of more than 14. Since I was able to 
successfully identify differentially expressed miRNA with this protocol, I extended the 
analysis to further tissues in order to ask whether the observed expression changes were 
specific to the thorax or a general miRNA response in all tissues.   
Thorax (Pre-test) 
miRNA Mean wt Mean dilp2-3,5 FC p-value p-value (adjusted) 
miR-980-3p 1506.10 819.86 0.54 0.002 0.04 
miR-274-5p 19618.64 14535.94 0.74 0.003 0.04 
miR-305-5p 11599.09 9390.98 0.81 0.01 0.07 
miR-998-3p 1001.22 816.01 0.82 0.04 0.23 
miR-263a-3p 29387.56 26889.01 0.91 0.01 0.06 
miR-124-3p 7590.66 8869.21 1.17 0.04 0.23 
miR-995-3p 4504.08 5352.13 1.19 0.02 0.12 
miR-304-5p 2.86 3.68 1.29 0.001 0.04 
miR-133-3p 2395.58 3088.96 1.29 0.02 0.12 
miR-932-5p 668.50 897.49 1.34 0.003 0.04 
miR-7-5p 129.24 174.14 1.35 0.01 0.08 
miR-957-3p 4769.43 6803.66 1.43 6.6 x 10-5 0.01 
miR-10-3p 249.48 358.31 1.44 0.003 0.04 
miR-307-3p 117.23 168.39 1.44 0.04 0.23 
miR-1017-3p 448.85 662.38 1.48 0.002 0.04 
miR-972-3p 2.88 4.36 1.52 0.02 0.15 
miR-1000-5p 342.44 534.47 1.56 0.01 0.07 
miR-1004-3p 296.16 463.78 1.57 0.003 0.04 
miR-999-3p 101.00 162.49 1.61 0.05 0.26 
miR-1001-5p 140.07 233.20 1.66 0.0001 0.01 
miR-981-3p 212.30 394.25 1.86 0.02 0.15 
miR-987-5p 70.54 138.56 1.96 0.001 0.04 
miR-989-3p 41.22 85.56 2.08 0.04 0.23 
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miR-87-3p 11.35 23.83 2.10 0.01 0.10 
miR-13a-3p 18.32 46.02 2.51 0.005 0.06 
miR-210-3p 1187.92 3110.32 2.62 0.03 0.18 
miR-954-5p 194.93 627.01 3.22 0.01 0.07 
miR-986-5p 36.64 525.31 14.34 0.001 0.04 
Table 1: Differentially expressed miRNAs detected in mechanically separated dilp2-3,5 thoraces used 
for the pre-test by microarray. Mean represents miRNA expression in three independent replicates 
each genotype. p-values are calculated by Student's t-test and adjusted by Benjamini-Hochberg 
procedure. FC, fold change; wt, wild type 
 
2.1.2 Drosophila tissues have characteristic microRNA expression profiles  
Based on the results from the pre-test, the miRNA microarray analysis was extended to three 
more tissues, namely the brain, the digestive tract and the abdomen. Furthermore, the analysis 
for the thorax was repeated. In contrast to the pre-test, thoraces for this experiment were 
manually dissected and thus exclude gut tissue (for dissection details see chapter 4.14). Three 
replicates were used per tissue. In addition, I used a newer generation of miRNA microarrays 
(Affymetrix GeneChip for miRNAs 2.0), which contained probe sets for 186 mature 
Drosophila miRNAs.  
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Figure 2.2: Comparisons of microarray tissue profiles. Pearson correlation coefficient for all pairwise 
comparisons was computed and the values are depicted color-coded. Samples from the same tissue 
cluster indicating high quality of tissue preparation and tissue-specific miRNA expression.   
 
In order to discover whether miRNAs are expressed in a tissue-specific manner and to verify 
reproducibility between tissue preparations, I tested the correlation of miRNA expression 
profiles by Pearson analysis. The Pearson coefficient gives information about the similarity in 
a pairwise miRNA profile comparison. Indeed, correlation coefficients between microarrays 
of the same tissue showed clustering indicating that each tissue had a unique miRNA 
expression profile and that tissue preparation was consistent between replicates (Figure 2.2).  
2.1.3 Identification of tissue-specific microRNAs by microarray  
Each tissue is characterized by a specific miRNA expression profile as discovered by Pearson 
correlation. In order to identify tissue-specific and ubiquitously expressed miRNAs, we 
qualitatively evaluated tissue specificity of single miRNAs by a tissue specificity score 
(Landgraf  et al., 2007). The calculation of the score is based on quantification of information, 
based on the information-theoretic concept of Claude Elwood Shannon (Shannon,  1948). It 
takes into account the distribution of the cloning frequencies in each tissue. The tissue-
specificity score is dependent on the number of tissues and varies between 0, when the 
expression of a miRNA is evenly distributed across tissues, and 2 when a miRNA is highly 
specific for a given tissue (Landgraf  et al., 2007). MiRNAs with expression under the 
detection threshold were filtered out in the analysis. We identified miRNAs whose expression 
is evenly distributed across tissues, such as miR-317-3p and miR-276a-3p (Figure 2.3). 
However, many miRNAs were expressed in a tissue-specific manner. Interestingly, most 
tissue-specific miRNAs were expressed in the brain, including miR-981-3p and miR-990-5p. 
We also found miRNAs specific for abdomen, like miR-2494-5p and miR-1015-3p, and 
miRNAs specific for digestive tract, like miR-314-3p and miR-956-3p. Only few miRNAs 
were specific for the thorax, like miR-993-3p. 
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Figure 2.3: Tissue specificity of miRNA expression as detected by microarray analysis in wild type 
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flies. The total length of each bar represents the tissue specificity and the relative length for each of 
the tissues are proportional to miRNA expression in a given tissue type relative to all tissue types. 
Only miRNAs with an expression value of 15 or greater were included in the analysis. 
 
2.1.4 Evolutionary conservation of microRNAs does not correlate with expression level 
as detected by microarray 
In diverse species including Drosophila it was shown that evolutionarily conserved miRNAs 
normally have higher expression levels than non-conserved miRNAs (Ruby et al., 2006; Ruby 
et al., 2007; Bartel, 2004). In order to examine whether highly evolutionarily conserved 
miRNAs are stronger expressed than less conserved miRNAs in our microarray study, I 
compared the phylogenetic conservation of miRNAs with their expression level. miRNAs 
were ranked in five classes according to the degree of evolutionary conservation. I 
distinguished between miRNAs that were found to be unique for Drosophila melanogaster, or 
conserved in Drosophilidae, insects, Ecdysozoa and Bilateria. To assign a miRNA to a 
conservation class, I searched for miRNA family members in other species as annotated on 
miRBase and examined the phylogenetic relation to D. melanogaster. In contrast to the 
previous studies, with a Pearson correlation coefficient of 0.03 I found no correlation between 
expression level and evolutionary conservation in our microarray data set (Figure 2.4 A).  
2.1.5 Expression level as detected by microarray does not correlate with tissue specificity 
Previous studies have suggested that miRNAs that are highly evolutionarily conserved tend to 
be ubiquitously expressed, while non-conserved miRNAs are expressed in a tissue-specific 
manner (Ruby et al., 2007). To analyze whether a similar trend was present in our microarray 
data set, I analyzed the correlation between evolutionary conservation and tissue specificity. 
Among tissue-specifically expressed miRNAs we found conserved as well as non conserved 
miRNAs (Figure 2.4 B). Expression of conserved miRNAs as well as non-conserved miRNAs 
was also found to be evenly distributed across tissues. Thus, with a Pearson correlation 
coefficient of -0.14, no correlation between degree of conservation and breadth of expression 
was found in adult tissues of Drosophila as detected by microarray. 
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Figure 2.4: Correlation of evolutionary conservation and tissue specificity or absolute expression of 
miRNAs, respectively. For both comparisons no correlation was observed. (A) Relationship between 
absolute expression and evolutionary conservation of miRNAs. (B) Relationship between tissue 
specificity and evolutionary conservation of miRNA expression as detected by microarray analysis.  
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2.1.6 Identification of differentially expressed microRNAs in four tissues of              
 dilp2-3,5 mutants 
In order to identify differentially expressed miRNAs in dilp2-3,5 tissues, the expression of 
single miRNAs was compared with the expression in wild type tissues. Differentially 
expressed miRNAs were detected in all tissues (Table 2-5). When assessed by row wise t-test, 
in the brain 6 miRNAs were significantly down-regulated and 5 were up-regulated. 2 
miRNAs were found to be down-regulated in the thorax and 11 were found to be up-
regulated. In the digestive tract of dilp2-3,5 flies 7 miRNAs were down-regulated while 4 
were up-regulated. In the abdomen 4 miRNAs were down-regulated and also 4 miRNAs were 
up-regulated. In total, 40 miRNAs were found to be differentially expressed in dilp2-3,5 
mutant flies. 7 miRNAs had a fold change over 1.5 or under 0.5, respectively. mir-986-5p had 
the highest fold change with 3.26 in the thorax. The strongest down-regulated miRNA was 
miR-2500-5p in the brain. Most miRNAs had a moderate fold change and were regulated 
tissue-specifically, however miRNAs like miR-986-5p and miR-978-3p were differentially 
regulated in more than one tissue. Some miRNAs like miR-285-3p or miR-1000-5p were 
down-regulated in one tissue, but up-regulated in other tissues, suggesting complex tissue-
specific miRNA regulation in response to reduced insulin signaling. However, a table-wide 
statistical test could not confirm significance for differential expression. 
Brain 
miRNA Mean wt Mean dilp2-3,5 FC p-value p-value (adjusted) 
dme-miR-2500-5p 77.83 39.54 0.51 0.00 0.19 
dme-miR-285-3p 32.87 20.41 0.62 0.02 0.52 
dme-miR-998-3p 1751.55 1142.64 0.65 0.02 0.52 
dme-miR-1014-3p 19.48 14.46 0.74 0.01 0.52 
dme-miR-2497-5p 14.96 11.86 0.79 0.01 0.52 
dme-miR-308-3p 18.98 16.41 0.87 0.05 0.78 
dme-let-7-5p 8804.45 10297.69 1.17 0.05 0.78 
dme-miR-9b-5p 13.44 18.25 1.36 0.02 0.52 
dme-miR-960-5p 13.82 18.78 1.36 0.01 0.52 
dme-miR-10-3p 1535.48 2109.08 1.37 0.04 0.78 
dme-miR-986-5p 59.28 141.32 2.38 0.02 0.52 
 
Table 2: Differentially expressed miRNAs in dilp2-3,5 brains as detected by microarray. Mean 
represents miRNA expression in three independent replicates of each genotype. P-values are 
calculated by Student's t-test and adjusted by Benjamini-Hochberg procedure. FC, fold change; wt, 
wild type 
 
Thorax 
miRNA Mean wt Mean dilp2-3,5 FC p-value p-value (adjusted) 
dme-miR-992-3p 17.52 13.34 0.76 0.05 0.44 
dme-miR-307b-5p 19.60 15.75 0.80 0.05 0.44 
dme-miR-276a-3p 36760.54 39592.58 1.08 0.05 0.44 
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dme-miR-2501-3p 16.24 18.12 1.12 0.03 0.44 
dme-miR-303-5p 18.17 22.50 1.24 0.02 0.44 
dme-miR-4-3p 14.98 18.72 1.25 0.01 0.44 
dme-miR-985-3p 16.77 22.34 1.33 0.04 0.44 
dme-miR-3-3p 42.06 59.84 1.42 0.03 0.44 
dme-miR-263b-3p 11030.76 15713.83 1.42 0.04 0.44 
dme-miR-1000-5p 224.59 332.69 1.48 0.04 0.44 
dme-miR-210-3p 659.88 1292.84 1.96 0.00 0.44 
dme-miR-954-5p 122.38 240.41 1.96 0.03 0.44 
dme-miR-986-5p 92.04 300.04 3.26 0.00 0.35 
 
Table 3: Differentially expressed miRNAs in dilp2-3,5 thoraces as detected by microarray. Mean 
represents miRNA expression in three independent replicates of each genotype. P-values are 
calculated by Student's t-test and adjusted by Benjamini-Hochberg procedure. miRNAs that were 
detected as differentially regulated in the pre-test are highlighted in bold. FC, fold change; wt, wild 
type 
 
Digestive tract 
miRNA Mean wt Mean dilp2-3,5 FC p-value p-value (adjusted) 
dme-miR-2494-5p 17.14 12.40 0.72 0.05 0.66 
dme-miR-12-5p 9301.95 6747.07 0.73 0.03 0.66 
dme-miR-1012-3p 35.93 27.56 0.77 0.02 0.66 
dme-miR-985-3p 24.38 20.20 0.83 0.02 0.66 
dme-miR-1004-3p 20.63 17.38 0.84 0.01 0.66 
dme-miR-1000-5p 16.75 14.15 0.84 0.03 0.66 
dme-miR-309-3p 15.88 13.81 0.87 0.05 0.66 
dme-miR-1011-3p 12.77 14.35 1.12 0.02 0.66 
dme-miR-927-5p 13.19 15.04 1.14 0.04 0.66 
dme-miR-978-3p 11.96 14.46 1.21 0.01 0.66 
dme-miR-2280-3p 13.98 17.88 1.28 0.05 0.66 
 
Table 4: Differentially expressed miRNAs in dilp2-3,5 digestive tracts as detected by microarray. 
Mean represents miRNA expression in three independent replicates of each genotype. p-values are 
calculated by Student's t-test and adjusted by Benjamini-Hochberg procedure. FC, fold change; wt, 
wild type 
 
Abdomen 
miRNA Mean wt Mean dilp2-3,5 FC p-value p-value (adjusted) 
dme-miR-308-3p 19.34 14.74 0.76 0.05 0.90 
dme-miR-iab-4-3p 16.76 13.33 0.80 0.01 0.75 
dme-miR-14-3p 17.15 13.81 0.81 0.00 0.75 
dme-miR-274-5p 27157.96 23190.94 0.85 0.01 0.75 
dme-miR-1004-3p 15.39 18.14 1.18 0.03 0.90 
dme-miR-1009-3p 14.99 18.46 1.23 0.02 0.75 
dme-miR-285-3p 15.19 23.84 1.57 0.04 0.90 
dme-miR-978-3p 15.57 41.03 2.64 0.03 0.90 
 
Table 5: Differentially expressed miRNAs in dilp2-3,5 abdomen as detected by microarray. Mean 
represents miRNA expression in three independent replicates of each genotype. p-values are 
calculated by Student's t-test and adjusted by Benjamini-Hochberg procedure. FC, fold change; wt, 
wild type 
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2.1.7 MicroRNA expression in the thorax as detected by microarray is reproducible  
 2.1.7.1 Verification of differentially expressed microRNAs in independent thorax 
   samples 
To assess whether data are reproducible between independent sample preparations, results 
from manually dissected thoraces were compared with the results of the pre-test where 
mechanically dissected thoraces were used. Only miRNAs with probe sets on both chips were 
analyzed. Consistent with the observation from the pre-test that most differentially expressed 
miRNAs were up-regulated in the thorax, in manually dissected thoraces only two miRNAs 
were down-regulated and 11 miRNAs were up-regulated (Table 3). In comparison with the 
pre-test, we detected less miRNAs to be significantly differentially expressed in the thorax 
with the new chips. Due to technical problems with these chips, two of three replicates for      
dilp2-3,5 thoraces had to be hybridized for a second time with the same RNA. To check 
whether the second hybridization influences miRNA profiles, we analyzed correlation of the 
chips by Pearson. Indeed, profiles from chips which were hybridized twice were most distinct 
from the other profiles (Figure 2.5 A).  
To test whether this technical variation affected the identification of differentially expressed 
miRNAs, we used Pearson correlation to compare detected fold changes of the pre-test and 
the manually dissected thoraces. The fold change profiles had a relative low Pearson 
correlation index of 0.36 (Figure 2.5 B). However, miRNAs which were significantly 
differentially expressed, were to a large extend congruent between the two chips (Table 3) 
Thus, the second hybridization did affect the sensitivity of detection of fold changes of 
miRNAs, but it had minor effects on the identity of differentially expressed miRNAs. 
Therefore, thorax miRNA expression data are consistent and reproducible between 
independent sample preparations and additionally, between different types of microarray.  
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Figure 2.5: Comparison of thorax profiles of microarray 1.0 (pre-test) and microarray 2.0. (A) Absolute 
expression profiles. Pearson correlation coefficient for all pairwise comparisons was computed and 
the values are depicted color-coded. Only miRNAs with probe sets on both chips are analyzed. 
Samples from the same chip-type cluster. Chips that were hybridized twice due to technical reasons 
are marked with asterisks. Notably, profiles from chips that were hybridized for a second time, show 
strong clustering and were most distinguishable from other profiles. (B) Comparison of fold change 
data as detected by microarrays 1.0 (pre-test) and microarrays 2.0. Pearson correlation coefficient of 
fold change data was computed and revealed low correlation. FC, fold change; wt, wild type. 
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 2.1.7.2 Verification of differentially expressed microRNAs by quantitative       
     RT-PCR 
In order to verify the results from the microarray analysis, expression of selected miRNAs 
was tested by quantitative Real-time-PCR (q-RT-PCR). Due to limited availability of 
dissected tissue, the same RNA samples that were used for microarray experiments were also 
used for the qRT-PCR analysis.  
Upregulation of miR-986-5p and downregulation of 2500-5p in the brain was confirmed by 
qRT-PCR (Figure 2.6 A). In contrast, downregulation of miR-285-3p as measured by 
microarray, could not be confirmed by qRT-PCR. miR-986-5p, miR-210-3p and miR-1000-5p 
were all up-regulated by microarray analysis in the thorax. Although upregulation did not 
reach significance, similar tendencies were observed in the qRT-PCR analysis (Figure 2.6 B).  
Additionally, differential expression of miR-2500-5p, which was significantly down-regulated 
in the brain, was tested in the thorax. By microarray miR-2500-5p showed a non-significant 
tendency to be down-regulated. However, qRT-PCR revealed a significant down-regulation in 
this tissue. Because we could verify differential expression of selected miRNAs in the brain 
and in the thorax, we tested whether those miRNAs were also differentially expressed in 
digestive tract and abdomen. By microarray, miR-210-3p, miR-285-3p, miR-986-5p and  
miR-2500-5p tended to be differentially expressed in the digestive tract (Figure 2.6 C). This 
tendency was reproduced by qRT-PCR. In the abdomen upregulation of miR-285-3p by 
microarray was observed. By qRT-PCR a tendency of upregulation of miR-285-3p was 
confirmed, although this was not significant (Figure 2.6 D). Microarrays could not detect 
differential expression of miR-210-3p in the abdomen and this was confirmed by qRT-PCR. 
However, miR-986-5p, which had a tendency of up-regulation by microarray was confirmed 
to be up-regulated significantly by qRT-PCR. miR-2500-5p expression was not changed as 
detected by microarray. However, qRT-PCR revealed that it is down-regulated by trend in the 
abdomen, like in every other tissue analyzed.  
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Figure 2.6: qRT-PCR analysis verifies differential expression of most miRNAs in dilp2-3,5 tissues as 
detected by microarrays. Fold change in (A) brain, (B) thorax, (C) digestive tract and (D) abdomen 
from microarray and qRT-PCR analysis are compared. * p<0.05; ** p<0.01,Student's t-test for qRT-
PCR, Benjamini-Hochberg for microarray data. miRNA transcript level was normalized to wild type 
samples, which by default was set to 1. 
 
Taken together, miRNAs are tissue-specifically expressed in Drosophila. Tissue-specificity or 
expression level did not correlate with evolutionary conservation, when assessed by 
microarray. Differentially expressed miRNAs in dilp2-3,5 mutants were found by microarray. 
By qRT-PCR differential expression for most miRNAs was confirmed. Interestingly, 
differentially expressed miRNAs, such as miR-2500-5p and miR-986-5p, which by 
microarray were found to be differentially expressed in brain and thorax, were also regulated 
in digestive tract and abdomen of dilp2-3,5 flies. These results suggest that the sensitivity of 
microarrays may be limiting for some miRNAs to detect differential expression and 
demonstrates that verification by qRT-PCR is essential to conclude about tissue-specific 
regulation. 
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2.2 Functional in vivo characterization of differentially expressed microRNAs  
By microarray, differentially expressed miRNAs were identified. These miRNAs might 
execute functions that mediate phenotypes observed for dilp2-3,5 flies such as lifespan 
extension, reduced organismal growth, reduced fecundity and increased development time. 
MiRNAs with significant expression fold change of >1.5 or <0.5 were selected to analyze 
their role in IIS related phenotypes (Fig. 2.7 A). These included miR-986, miR-210, miR-954, 
miR-285 and miR-978. Although, miR-7 did not match the selection criteria, it was included 
in the analysis to represent a differentially expressed miRNA in the digestive tract. 
Additionally, miR-2500 was added to the analysis because of a consistent and reproducible 
down-regulation in every tissue also in other Drosophila IIS mutants and under different food 
conditions (Supplemental Figure S1). 
 
Figure 2.7: Overexpression of candidate miRNAs is achieved by the Gal4/UAS system.                 
(A) Candidate miRNAs as detected by microarray in dilp2-3,5 tissues of Drosophila melanogaster. 
Shown are miRNAs with a significant expression fold change of more than 1.5 or less than 0.5 in 
comparison to wild type tissues with p<0.05, Student's t-test. (B) The Gal4/UAS system for miRNAs 
in Drosophila melanogaster. In flies generated by the cross of a driver-line to an UAS-line, Gal4 is 
expressed in a promoter-dependent manner and can activate transcription of the miRNA by binding 
to upstream activation sites (UAS). (C) Transgene construct used to generate UAS lines. 
Transgenic flies contain 500 bp of the genomic region of the miRNA precursor under the control of 
the hsp70 TATA UAS (5x). The construct also includes DsRed2 and a SV40 polyadenylation 
(polyA) signal. UAS-lines were kindly provided by Dr. Eric Lai. 
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To study their function, candidate miRNAs were overexpressed in vivo using the Gal4/UAS 
system (Figure 2.7 B). For each miRNA UAS-overexpression lines were kindly provided by 
Dr. Eric Lai from the Sloan Ketterin Institute, New York. The inserted overexpression 
transgene included approximately 500 bp of the genomic region including the miRNA 
precursor cloned into a vector containing the hsp70 promoter with 5 UAS sites and DsRed for 
visualization of overexpression (Figure 2.7 C). 
2.2.1 Organismal growth and development time of flies overexpressing microRNAs 
dilp2-3,5 mutants have a reduced body weight due to decreased organismal growth and a 
severely increased development time (Grönke et al., 2010). In order to investigate a putative 
role of the candidate miRNAs in the regulation of body size and developmental timing, body 
weight and egg to adult development time of flies with ubiquitous overexpression of miRNAs 
during development were determined. Overexpression of miR-2500 and miR-954 did not 
affect body weight (Figure 2.10 A) nor development time (Figure 2.10 B), suggesting that 
those miRNAs do not play an important role during development. Overexpression of miR-986 
also had no effect on body weight, but these flies were slightly developmental delayed. The 
delay of male flies was stronger than of female flies, suggesting that miR-986 might regulate 
development time in a gender-specific manner.    
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Figure 2.8: Body weight and development time of flies overexpressing miR-986, miR-2500 or miR-
954. (A) Body weight of flies overexpressing miR-986, miR-2500 or miR-954 was not changed in 
both sexes. Flies were measured in pairs, therefore results reflect the mean body weight of two 
flies. n=20 flies per genotype and sex. (B) Overexpression of miR-986, but not miR-2500 or miR-
954 did increase development time in both sexes. 
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2.2.2 Lifespan and fecundity of strongly ubiquitously overexpressed microRNAs  
In order to analyze whether selected candidate miRNAs might play a role in lifespan 
regulation, these miRNAs were overexpressed and lifespan of overexpressing flies was 
measured. For overexpression we used the constitutive tubulin-Gal4 driver line, which drives 
strong ubiquitous expression both during development and adulthood. Overexpression of 
miR-978 and miR-7 caused embryonic lethality, suggesting toxic effects during development. 
To bypass developmental lethality, both miRNAs were overexpressed using an inducible 
tubulin-GeneSwitch (tubulinGS) driver, which allows expression to be restricted to adulthood 
(Osterwalder et al., 2001). Degree of induced overexpression was measured by qRT-PCR. 
Overexpression of miR-285 was not detected; therefore miR-285 was excluded from further 
analysis (Supplemental Figure S2). In all other tested miRNA lines, strong overexpression 
ranging from 26.71- to 791.24-fold was detected (Figures 2.9 and 2.10). Adult-specific 
overexpression of miR-978 and miR-7 resulted in a severe reduction of median lifespan by 
22.14 % (Figure 2.10 A) and 71.43 % (Figure 2.10 B), respectively. This reduction in adult 
lifespan is consistent with their detrimental role upon overexpression during development. 
Overexpression of miR-986 and miR-954 caused moderate but significant reduction in 
lifespan (Figure 2.9 A, C) while overexpression of miR-2500 did not significantly affect 
lifespan compared to controls (Figure 2.9 B). 
In order to analyze the role of selected miRNAs in the regulation of fecundity, egg production 
of miRNA overexpressing flies was measured. Adult-specific overexpression of miR-978 
(Figure 2.10 A) and miR-7 (Figure 2.10 B) resulted in severe reduction in fecundity. In 
contrast, egg production of flies overexpressing miR-986, was only slightly reduced (Figure 
2.9 A) and fecundity of miR-2500 or miR-954 overexpressing flies was not changed 
compared to controls (Figure 2.9 B, C).  
In summary, tubulin-Gal4/GS mediated overexpression of miRNAs negatively affected 
lifespan and fecundity, suggesting that strong ubiquitous overexpression of the selected 
miRNAs is detrimental for fly health.  
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Figure 2.9: Expression level, lifespan and fecundity of flies overexpressing miRNAs with a strong 
ubiquitous driver. Overexpression of (A) miR-986, (B) miR-2500 and (C) miR-954 with tubulin-Gal4 
was confirmed by qRT-PCR. * p<0.05,Kruskal-Wallis test, Dunn's test for multiple comparisons. 
Lifespan of miR-986 or miR-954 overexpressing flies were shortened compared to both controls, 
respectively (*** p<0.001, log-rank test). Survival of miR-2500 overexpressing flies was not changed 
compared to the tubulin-Gal4 control. Fecundity of miR-986 and miR-954 overexpressing flies was 
reduced and not changed for flies overexpressing miR-2500. ** p<001, Kruskal-Wallis test, Dunn's 
test for multiple comparisons.  
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Figure 2.10: Expression level, lifespan and fecundity of flies overexpressing miRNAs with a strong 
ubiquitous inducible driver. Overexpression of (A) miR-978 and (B) miR-7 with tubulin-GS was 
confirmed by qRT-PCR. ***p<0.001, Kruskal-Wallis test, Dunn's test for multiple comparisons. 
Lifespan of miR-978 or miR-7 overexpressing flies is shortened (*** p<0.001, log-rank test). 
Fecundity of miR-978 and miR-7 overexpressing flies was dramatically reduced. *** p<001, Kruskal-
Wallis test, Dunn's test for multiple comparisons. 
 
2.2.3 Lifespan of mildly ubiquitously overexpressed microRNAs 
In contrast to the very strong overexpression achieved by the tubulin-Gal4 driver (Figures 2.9 
and 2.10) miRNAs that were identified in the microarray analysis only showed small fold 
changes in the range of 1.5-14 fold induction in the dilp2-3,5 mutants compared to controls 
(see chapter 2.1.6). As strong overexpression was detrimental to flies, we reasoned that 
induction that resembles more the physiological conditions might cause different, beneficial 
effects on lifespan. In order to achieve low-level overexpression of specific miRNAs we used 
the UAS-miRNA lines in combination with the inducible daughterless-GeneSwitch (da-GS) 
driver (Figure 2.11). To determine the right induction conditions, i.e. concentration of RU486, 
for the lifespan analysis, flies were fed with increasing concentrations of RU486 (10, 25 and 
50 µM) and miRNA induction was analyzed by qRT-PCR. As shown in Figure 2.11 
expression level of miRNA increased with increasing amounts of RU486 and overall 
expression induction was smaller than when using the tubulin-Gal4 or tub-GS driver lines 
(compare Figure 2.11 with 2.9 and 2.10). Accordingly, lifespan was not decreased upon mild 
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overexpression of miR-986, miR-954 or miR-978, however, lifespan was also not increased. 
Ubiquitous overexpression of miR-210 with the da-GS driver still resulted in decreased 
median lifespan, demonstrating that even mild overexpression of this miRNA is detrimental 
for survival. In summary, none of the tested miRNAs caused lifespan extension upon 
moderate ubiquitous overexpression. 
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Figure 2.11: Survival and expression level of flies overexpressing miRNAs with the ubiquitous da-GS 
driver line. Overexpression using different RU-concentrations of (A) miR-986, (B) miR-210, (C) miR-
954 and (D) miR-978 with da-GS was confirmed by qRT-PCR. * p<0.05, Kruskal-Wallis test, Dunn's 
test for multiple comparisons. Expression of miRNAs was directly correlated to RU486 (RU) 
concentration in the food. Overexpression of miR-986 or miR-954 did not affect lifespan, 
overexpression of miR-210 decreased lifespan (** p<0.01, log-rank test).  
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2.2.4 Lifespan analysis upon tissue-specific overexpression of microRNAs 
miRNAs were up-regulated in specific tissues of dilp2-3,5 mutants and maybe tissue-
specificity is important for lifespan regulation. In order to test this hypothesis, we 
overexpressed the miRNAs in a tissue-specific manner according to which tissue they were 
up-regulated in the dilp2-3,5 mutant flies (Figure 2.12). miR-210 and miR-954 were 
differentially expressed in the thorax, which consists to a large extend of muscle tissue. 
However, overexpressing miR-210 or miR-954 specifically in the muscle using the MHC-
Gal4 driver did not change lifespan compared to the controls. Similarly, overexpression of 
miR-978, which was found to be differentially expressed in the abdomen, with the abdominal 
fat body specific driver S106-GS had no effect on lifespan. Therefore, tissue-specific 
overexpression of the selected candidate miRNAs had no beneficial effect on lifespan.  
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Figure 2.12: Survival and expression level of flies overexpressing miRNAs with tissue-specific drivers. 
Overexpression of (A) miR-210 and (B) miR-954 with the muscle-specific MHC-Gal4 driver and 
overexpression of (C) miR-978 with the fat-body specific S106-GS driver using different RU-
concentrations was confirmed by qRT-PCR (* p<0.05, Wilcoxon rank-sum test, Mann-Whitney for (A) 
and (B), Kruskal-Wallis test, Dunn's test for multiple comparisons for (C)) but did not change lifespan 
compared to controls. 
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2.3 The Drosophila miR-986 knock-out mutant 
2.3.1 Generation of a Drosophila miR-986 knock-out mutant  
miR-986 was one of the most strongly induced miRNAs in dilp2-3,5 flies according to the 
microarray analysis, however, its function is currently unknown. Therefore I decided to study 
miR-986 in vivo function by generating a loss-of-function mutant. The miR-986 precursor is 
located on the right arm of the 2nd chromosome, in sense orientation within the 3rd intron of 
the protein coding Cyp4e2 gene (Fig. 2.13 A). Cyp4e2 encodes for a cytochrome P450, an 
enzyme with oxidoreductase activity. Cytochrome P450s are suggested to be involved in the 
metabolism of insect hormones and the breakdown of insecticides (Chung et al., 2009). 
Cyp4e2 was recently identified as a putative methanol metabolizing enzyme (Wang et al., 
2012).  
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Figure 2.13: Generation of a miR-986 knock-out mutant (miR-986
KO
). (A) Ends-out homologous 
recombination was used to generate knock-out mutants of the miR-986 gene which is located on the 
right arm of the 2nd chromosome, within the 3rd intron of Cyp4e2. (B) PCR verified the knock-out of 
miR-986 in three independent targeting lines as well as in miR-986
KO* 
which excludes the mini-white 
gene. (C) Cyp4e2 expression was affected in miR-986
KO
 lines as tested by qRT-PCR and restored by 
removal of the mini-white marker.  
 
In order to generate a Drosophila mir-986 loss-of-function mutant (miR-986
KO
) I used ends-
out homologous recombination (Gong et al., 2003). In the first step, the miR-986 precursor 
gene was replaced by homologous recombination with a mini-white marker gene. Knock-out 
of miR-986 was verified by PCR with primers 185 and 186 (Figure 2.13 B). These primers 
produce a 535 bp fragment on wild type genomic DNA and no fragment on mir-986 knock-
out mutants. Three mutant lines from independent targeting events were verified and used for 
further analysis. In order to test whether Cyp4e2 expression was affected by insertion of the 
mini-white gene in these lines, qRT-PCR was performed (Figure 2.13 C). A slight but 
significant decrease in expression of Cyp4e2 was detected: line #1 showed 27 %, line #2 44 % 
and line #3 48 % reduction. Thus, Cyp4e2 is affected but still expressed in miR-986
KO
 
mutants. In order to restore Cyp4e2 expression to wild type levels, the mini-white marker 
gene was removed from the mir-986 locus by Cre recombinase-mediated excision for one of 
the three miR-986
KO
 lines. Excision of the marker gene was verified by eye color and deletion 
of miR-986 was verified by PCR using primers 185 and 186. Removal of the white marker 
gene fully restored wild type expression levels of Cyp4e2 (Figure 2.13 C).  
2.3.2 In vivo characterization of miR-986
KO 
mutants 
For in vivo analysis three miR-986
KO
 lines including the white gene were used. Homozygous 
miR-986
KO
 mutant flies were viable and had no visible obvious phenotypes. Therefore, I 
analyzed their body weight, development time, lifespan, fecundity and stress resistance, all 
phenotypes that are affected by mutations in IIS (Figures 2.14 and 2.15).  
Reduced IIS in flies causes reduced body size and a delay in development (Weinkove and 
Leevers, 2000; Rulifson  et al., 2002; Grönke et al., 2010). Therefore, body weight  and egg 
to adult development time of the three miR-986
KO
 mutants lines was assessed. miR-986
KO
 
males and females had normal body weight, suggesting that miR-986 does not regulate 
organismal growth (Figure 2.14 A). 
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Figure 2.14: Body weight, development time, survival and fecundity of miR-986
KO
 mutants. (A) Body 
weight of miR-986
KO
 females and males was not changed. Flies were weighed in pairs. (B) Egg-to-
adult development time of miR-986
KO
 mutant females and males. Only the hatching period of adult 
flies is shown. Two of three independent miR-986
KO
 lines hatched earlier than wild type flies. (C) 
Survival curves of miR-986
KO
 mutants. Female and male lifespan was decreased. *** p<0.001, log-
rank test. (D) Fecundity of female miR-986
KO 
flies was decreased. *** p<0.001, Wilcoxon rank sum 
test. 
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Development time of two miR-986
KO
 strains was slightly shortened for males and for females 
(Figure 2.14 B). However, one strain had the same development time as wild type flies. 
Therefore, the shortened development time of the two other strains is likely to be a non-
specific, miR-986-independent effect. Survival analysis of the three miR-986
KO
 lines revealed 
that lifespan of miR-986
KO
 males and females was reduced, suggesting that miR-986 is 
required for normal lifespan (Figure 2.14 C). Fecundity of miR-986
KO
 flies was also reduced 
as flies of all three miR-986
KO
 lines laid about 37 % less eggs than wild type flies suggesting 
that miR-986 might be involved in the regulation of fecundity (Figure 2.14 D). 
dilp2-3,5 mutants were shown to be resistant to oxidative stress including paraquat and H2O2 
(Grönke et al., 2010). If miR-986 mediates resistance to oxidative stress in dilp2-3,5 mutants, 
miR-986
KO
 flies are expected to be sensitive to these stresses. In contrast, miR-986
KO
 flies 
survived significantly longer when exposed to paraquat (Figure 2.15 A). This suggests a 
putative role for miR-986 in the regulation of paraquat resistance but not in dilp2-3,5 
mediated paraquat resistance. When exposing miR-986
KO 
flies to H2O2 only one of three lines 
had reduced resistance (Figure 2.15 B). Therefore, miR-986 most likely does not account for 
H2O2 resistance. 
Mutants with reduced IIS activity were shown to tolerate starvation conditions better than 
wild type flies as a result of suppressed nutrient storage and cell growth and the enabling of 
nutrient mobilization by energy storing tissues (Britton et al., 2002). miR-986
KO
 flies were 
sensitive to starvation, suggesting a putative role of miR-986 in the regulation of starvation 
response (Figure 2.15C). However, dilp2-3,5 mutants do not have increased starvation 
resistance (Grönke et al., 2010). Therefore, it is likely that reduced starvation tolerance of 
miR-986
KO
 mutants is independent of IIS.   
dilp2-3,5 mutants were shown to be resistant to the xenobiotic DDT (Grönke et al., 2010). 
Only one of three lines of miR-986
KO
 was significantly resistant to DDT (Figure 2.15 D). In 
the DDT assay miR-986
KO
 and wild type flies were kept separately on food containing the 
drug. Strikingly, over time the surface of the food of the mutants but not of wild type became 
smeary, most probably due to bacterial contamination. As this could affect the response to 
DDT, the assay was performed again, with wild type and miR-986
KO
 flies in same vials where 
flies were distinguished by eye color. When both genotypes were pooled, still only one of 
three miR-986
KO 
lines survived longer than wild type. Therefore, miR-986 does not mediate 
the response to DDT.  
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Figure 2.15: miR-986
KO 
performance under stress conditions. miR-986
KO
 flies were exposed to 
paraquat (A), H2O2 (B), starvation (C) and DDT (D). (A) Survival under H2O2 stress was decreased for 
one of three miR-986
KO
 lines. (B) Stress tolerance of miR-986
KO
 flies against paraquat was increased. 
(C) Starvation reduced the lifespan of miR-986
KO
 flies. (D) Only one miR-986
KO
 line had increased 
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lifespan in the first experiment. The second experiment was done with pooled wild type and          
miR-986
KO
 flies in same vials (for details see text). Still, only one of three miR-986
KO
 lines was longer-
lived. For each drug treatment two replicate experiments are shown. * p<0.05; ** p<0.01; *** p<0.001, 
log-rank test. 
 
2.3.3 Putative targets of miR-986 
miRNAs regulate gene expression by silencing target mRNAs. To find putative targets of 
miR-986, the miRanda algorithm was used (Enright et al., 2003). This algorithm predicts 
targets based on sequence complementarity, free energies of RNA-RNA duplexes and 
evolutionary conservation of target sites. In order to rank predicted targets the mirSVR 
method was used (Betel et al., 2010). Using the miRNA.org source that combines miRanda 
algorithm with the mirSVR method (Betel et al., 2008), predicted targets of miR-986 were 
identified (Table 6). The predicted miR-986 targets were shown to be involved in diverse 
functions including olfactory learning, dopamine secretion, mitosis, phagocytosis, histone 
actetylation, reproduction, notch signaling, glycogen biosynthesis, brain development and 
fatty acid biosynthesis. Targets involved in detoxification of superoxide were not predicted.  
Putative 
Target ID 
mirSVR 
score Biological function 
klg NM_079730 -1.85 
homophilic cell adhesion; behavioral response to 
ethanol; long-term memory (olfactory learning); R7 
cell differentiation. 
CG10338 NM_136053 -1.7 unknown 
Ih NM_001038859 -1.59 
determination of adult lifespan; positive regulation 
of circadian sleep/wake cycle, locomotor rhythm; 
transmembrane potassium ion transport; proboscis 
extension reflex; regulation of dopamine secretion. 
larp NM_080259 -1.57 
spindle assembly involved in male meiosis; 
mitochondrion inheritance; salivary gland cell 
autophagic cell death; centrosome separation; 
mitotic chromosome condensation. 
ATPsyn-b NM_168365 -1.51 
phagocytosis; ATP synthesis coupled proton 
transport. 
CG10492 NM_136093 -1.48 unknown 
msl-1 NM_057548 -1.41 
histone H4-K16 acetylation; complex assembly 
involved in dosage compensation by 
hyperactivation of X chromosome. 
CG10433 NM_137746 -1.36 reproduction; defense response. 
CG32479 NM_167844 -1.34 
positive regulation of Notch signaling pathway; 
ubiquitin-dependent protein catabolic process. 
Glycogenin NM_166432 -1.34 glycogen biosynthetic process. 
CG2790 NM_138142 -1.31 unknown 
fdl NM_165908 -1.3 brain development; N-glycan processing 
CG2781 NM_141497 -1.3 very long-chain fatty acid biosynthetic process. 
Table 6: Putative miR-986 targets as predicted by miRDeep algorithm. Scores are calculated by 
mirSVR. 
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In summary, miR-986 did not modulate body size, development time and the response to 
H2O2 or DDT. However, miR-986 seemed to be required for normal lifespan, egg-production 
and starvation resistance, as miR-986
KO
 flies were short-lived, laid fewer eggs and were 
sensitive to starvation. Lack of miR-986 significantly increased paraquat resistance, 
suggesting that miR-986 might target genes involved in the detoxification of superoxide. 
However, currently we cannot exclude that down-regulation of Cyp4e2 expression in        
miR-986
KO
 flies might contribute to the observed phenotypes. The repetition of the 
experiments with the miR-986
KO*
 line without the white gene and fully restored Cyp4e2 
expression will answer this question. 
 
2.4 Next-generation sequencing of Drosophila tissues 
2.4.1 Establishment of a small RNA preparation protocol for deep sequencing of 
nDrosophila microRNAs 
 2.4.1.1 Standard microRNA library generation resulted in ribosomal                    
         RNA contamination 
In addition to microarray analysis, miRNA expression can also be analyzed by next 
generation sequencing. Next generation sequencing offers several advantages over microarray 
analysis. Sequencing discriminates highly similar sequences and can distinguish miRNA 
family members and isoforms on the basis of single nucleotides. Furthermore, it allows the 
detection of editing events and even unknown small RNAs, e.g. of the 238 miRNAs currently 
annotated in MirBase, only 186 are represented on the Affymetrix GeneChip 2.0. Thus, in 
order to analyze miRNA expression by an independent method and to cover all possible 
expressed miRNAs, we used next generation sequencing to profile tissue-specific miRNA 
expression in adult flies. 
In order to establish a protocol for RNA isolation that is compatible with next generation 
sequencing of miRNAs in Drosophila, we generated a test library from total RNA of the 
digestive tract of wild type flies. Total RNA, which was extracted and size-fractionated on a 
column to isolate small RNAs, served as input for the library. After adapter ligation the RNA 
was reverse transcribed and amplified by PCR. The generated library was then used for 
sequencing on an Illumina platform. 
Results 
 
39 
 
Sequencing of the gut library resulted in 20.83 million reads, however, only 1.94 % of the 
reads mapped to Drosophila miRNAs (Table 7). To identify the other 98.06 % non-miRNA 
sequences we performed a BLAST search on the Drosophila genome. This analysis revealed 
that most non-miRNA sequences matched to ribosomal RNAs, particularly 2S rRNA. The 
proportion of rRNA in the library amounted to 96.33 %, with 91.01 % identified as 2S rRNA. 
1.73 % of all sequences failed to align to miRNAs or rRNAs. Thus, the standard protocol of 
library preparation was not suitable for deep sequencing of Drosophila miRNA expression. 
 column fractionation  Protocol A Protocol B Protocol C 
# x 106 reads analyzed  20.83 26.59 12.33 23.57 
% reads mapped to 
Drosophila miRNA 1.94 3.84 1.01 4.31 
% reads mapped to rRNA 96.33 33.22 66.20 29.27 
% reads mapped to 2S rRNA  91.01 1.34 45.54 1.20 
% reads not mapped to 
Drosophila rRNA or miRNA  1.73 62.94 32.79 66.42 
 
Table 7: Comparison of different methods for miRNA library preparation. 
 
 2.4.1.2 Optimization of microRNA library preparation 
Drosophila 2S rRNA is expressed at higher levels than miRNAs and with 30 nt has a similar 
size as miRNAs, which are on average 22 nt long. Thus standard column fractionation may 
not be sufficient to separate miRNAs from 2S rRNA. In order to generate miRNA next 
generation libraries with lower 2S rRNA contamination, three different approaches were 
tested: (A) gel purification of 15-27 nt small RNAs, (B) oligo-depletion of 2S RNA and (C) 
combination of A and B (Figure 2.16). To test the three methods, total RNA of digestive tracts 
of wild type flies was used consistent with the pre-test library (2.4.1.1).  
Sequencing of library A resulted in 26.59 million reads. Importantly, the percentage of rRNA 
in the library was significantly reduced from 96.33 % to 33.22 % (Table 7), whereby            
2S rRNA content was reduced from 91.01 % to 1.34 %, demonstrating that gel purification is 
an efficient method to avoid 2S rRNA contamination. Reads mapping to miRNA were 
increased from 1.94 % to 3.84 %. Noteworthy, the amount of reads which did not map to 
Drosophila miRNAs or rRNAs was increased from 1.73 % to 62.94 % (compare 2.4.3). 
Overall sequencing depth was lower in the oligo-depleted library B, resulting in only 12.33 
million reads. rRNA and particularly 2S rRNA was reduced to 66.2 % and 45.54 %, 
respectively, demonstrating that oligo depletion was less efficient in removing rRNA 
contamination than gel purification. The amount of reads mapping to miRNA was decreased 
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to 1.01 % and therefore even lower than in the standard protocol. Reads that could not be 
mapped to miRNAs or rRNAs represented 32.79 % of all analyzed reads, which is lower than 
in protocol A and probably the result of less efficient rRNA depletion. Combined gel 
purification and oligo-depletion of library C resulted  in 23.57 million reads, of which only 
29.27 % mapped to rRNA and 1.2 % to 2S rRNA sequences. These values are just slightly 
lower than the results of just the gel purification. Consistent with this finding, 4.31 % of the 
reads mapped to miRNAs, which is only slightly more than the 3.83 % of gel purification 
alone. Reads which did not map to miRNA or rRNA accounted for 66.42 % of all analyzed 
reads. Thus, in summary, oligo depletion combined with size selection only marginally 
improved rRNA depletion and miRNA enrichment compared to gel purification alone. 
Therefore, we decided to use gel purification (method A) for the generation of the libraries for 
the tissues of wt and dilp2-3,5 flies.   
 
 
Figure 2.16: Optimization of miRNA library preparation. In protocol A total RNA was size-separated 
on an acrylamide-urea gel and miRNAs were isolated from 2S rRNA by size selection. Protocol B 
used oligonucleotide-coated beads with antisense oligonucleotides to deplete 2S rRNA identified in 
the pretest-library. In protocol C both protocols are combined; Total RNA is size-selected on a 
polyacrylamide-urea gel and 2S rRNA is then depleted using oligonucleotide-coated beads. 
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2.4.2 Next generation sequencing of Drosophila tissues 
We used total RNA isolated from brain, thorax, digestive tract and abdomen of wild type and 
dilp2-3,5 flies to generate 24 miRNA libraries (3 replicates per tissue and genotype). Libraries 
were sequenced using Illumina technology and the number of reads per library varied between 
9 and 36 million reads (Table 8).
 
Gel purification of miRNAs (protocol A, see 2.4.1.2) resulted in low level of rRNA 
contamination in all libraries. Brain libraries contained on average 4 %, thorax libraries 6 % 
and abdomen libraries 4 % reads mapping to rRNA sequences. The digestive tract showed the 
highest rRNA contamination with 17.32 % of all reads. Thus, the used protocol successfully 
reduced the amount of rRNA in all tissues although to varying degree.   
The percentage of analyzed reads that mapped to Drosophila miRNA varied between tissues. 
In libraries originating from brain, thorax and abdomen 82 %, 71 % and 73 % of the reads 
mapped to miRNAs, respectively. In contrast, libraries made from the digestive tract 
contained significantly less reads mapping to miRNA sequences, only 16 % of all reads 
mapped to miRNAs.  
A miRNA was defined as detected when the normalized read count was more than 10. With 
this stringent criterion, between 109 and 159 distinct mature miRNAs were detected, on 
average 134 miRNAs per library. Among replicates the normalized sequencing read count for 
miRNAs was similar, suggesting that the sequencing data are reproducible. Given a total 
number of 426 annotated mature Drosophila miRNAs (miRBase release 20) the average 
amount of detected distinct mature miRNAs in all libraries was 30.95 %. The microarray chip 
contained probe sets for 186 distinct miRNAs. The average amount of miRNAs detected over 
background by microarray was 22.82 % compared to all annotated miRNAs. Thus, next 
generation sequencing resulted in the detection of more miRNAs compared to the microarray 
analysis despite the stringent detection criterion used in the sequencing analysis.  
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2.4.3 Identification of non-microRNA reads 
A large part of the library reads did not map to the Drosophila genome (Table 8). 14.57 % of 
brain, 22.64 % of thorax and 22.73 % of abdomen library sequences did not map to either 
Drosophila miRNA or rRNA. For digestive tract the amount of reads that did not map to 
Drosophila miRNA or rRNA was the highest with 66.65 %.  
wDah and wDah; dilp2-3,5 flies used for the next generation sequencing analysis contain the 
intracellular endosymbiont Wolbachia pipientis (Grönke et al., 2010). In order to test whether 
reads that could not be mapped to the Drosophila genome may be originating from 
Wolbachia, we mapped the library sequences onto the Wolbachia genome (see chapter 
4.24.5). Indeed, in brain 0.36 %, thorax 1 %, digestive tract 1.13 % and in the abdomen      
1.82 % of all analyzed reads mapped to Wolbachia. Interestingly, in all tissues, the amount of 
sequences that map to Wolbachia was much higher in dilp2-3,5 flies than in wild type flies. 
Especially in the digestive tract the amount of reads corresponding to the Wolbachia genome 
was 11 times higher in dilp2-3,5 flies than in wild type.  
Since the food source of flies used in this experiment contained yeast, the library of digestive 
tract samples might be contaminated with yeast small RNA sequences. We therefore 
compared the analyzed sequences with the transcriptome of Saccharomyces cerevisiae by 
BLAST algorithm. Indeed, the amount of reads mapping to yeast sequences was low in brain 
(1.35 %), thorax (3.84 %) and abdomen (3 %), while with 30.64 % it was high in digestive 
tract. Thus, dietary yeast affected the digestive tract library composition.  
2.4.4 Tissue-specific microRNA expression profiles 
We used Pearson correlation analysis to analyze whether global miRNA expression profiles 
differs between tissues and genotypes and whether tissue dissection was consistent between 
replicates (Figure 2.17). miRNA profiles of the same tissue type showed strong correlation 
indicating high similarity. Consistent with the microarray data, this indicated that Drosophila 
tissues have a characteristic miRNA expression profile. Furthermore, these results show that 
tissue preparation was consistent between the replicates and that profiles from wild type and 
dilp2-3,5 tissues showed strong correlation. 
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Figure 2.17: Comparisons of miRNA tissue profiles generated by next-generation sequencing. 
Pearson correlation coefficient for all pairwise comparisons was computed and the values are 
depicted color-coded. Samples of the same tissue cluster, indicating high quality of tissue preparation 
and tissue-specific miRNA expression.   
  
2.4.5 Identification of tissue-specific microRNAs by sequencing 
In order to analyze tissue specificity of miRNAs that were detected by next generation 
sequencing, a tissue specificity score was calculated as before for microarray data (see chapter 
2.1.3). miRNAs with less than 10 normalized reads were not included in the analysis. 
Sequencing data for tissue specificity highly correlated with microarray data with a Pearson 
coefficient of 0.72. Thus similar tissue specificity as for microarray data was found by 
sequencing data. We found ubiquitously expressed miRNAs and tissue-specific miRNAs 
(Figure 2.18). Consistent with the microarray results, miRNAs specific for the digestive tract 
included miR-314-3p and miR-956-3p. In the abdomen among others miR-2494-5p and   
miR-1015-3p were specifically expressed. Also by sequencing we found that most tissue-
specific miRNAs were expressed in the brain, like mir-981-3p and 990-5p. As observed 
before, miR-993-3p was specifically expressed in the thorax. While by microarray 30 
miRNAs were detected as tissue-specific, by sequencing 75 miRNAs had a tissue specificity 
score of more than 1.0. Thus by sequencing we were able to extend the information about 
tissue specificity to more miRNAs. For example miR-4916-3p is a miRNA with no probe set 
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on the array but by sequencing we found it to be highly specific for the brain. Also we found 
miRNAs, which were evenly expressed in all tissues, like let-7-5p. Tissue specificity of  
dilp2-3,5 miRNAs was altered compared to wild type (Supplemental Figure S3), suggesting 
differential regulation of spatial miRNA expression in dilp2-3,5 mutants. 
 
Figure 2.18: Tissue specificity of miRNA expression as detected by next-generation sequencing in 
wild type flies. The total height of each bar represents the tissue specificity and the relative heights for 
each of the tissues are proportional to miRNA expression in a given tissue type relative to all tissue 
types. miRNAs with at least 10 reads are included in the analysis. 
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2.4.6 Evolutionary conservation of microRNAs correlates with expression level as 
fdetected by sequencing 
Although it was shown in previous studies, that miRNA expression level correlates with 
degree of evolutionary conservation (Ruby et al., 2007), we could not verify this observation 
by microarrays (see chapter 2.1.4). In order to test whether in contrast our sequencing results 
can confirm the observation of previous studies we compared miRNA read number with 
degree of evolutionary conservation. By sequencing we found that the majority of miRNAs 
with high read number are highly evolutionary conserved whereas miRNAs with low read 
number are not conserved. Thus with a Pearson coefficient of 0.3 expression level of miRNAs 
correlated with evolutionary conservation. (Figure 2.19 A) 
2.4.7 Expression level as detected by sequencing does not correlate with tissue specificity 
It was published that highly expressed miRNAs are evenly distributed across tissues whereas 
low expressed miRNAs show higher tissue specificity (Ruby et al., 2007). I did not observe 
the same correlation in my microarray analysis (see chapter 2.1.5). In order to re-analyze this 
correlation on my next generation sequencing dataset, we compared miRNA tissue specificity 
with sequencing read count (Figure 2.19 B). As for microarrays, with a Pearson coefficient   
of -0.13 we found no correlation between evolutionary conservation and specificity of 
expression in adult tissues of Drosophila flies. 
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Figure 2.19: Correlation of evolutionary conservation of miRNAs and tissue specificity or absolute 
expression, respectively. Sequencing data was used for the analysis. (A) Relationship between 
absolute expression and evolutionary conservation of miRNAs. Strong correlation was observed as 
evolutionary conserved miRNAs are highly expressed. For a detailed list see supplemental table 1.  
(B) Relationship between tissue specificity of miRNA expression as detected by sequencing and 
evolutionary conservation. No correlation between tissue specificity and conservation was observed. 
Only miRNAs with a read number of >10 were included in the analysis.. 
 
2.4.8 Identification of differentially expressed microRNAs in dilp2-3,5 tissues by 
sequencing 
Global miRNA expression was highly similar between wt and dilp2-3,5 tissues (Figure 2.17). 
However, single miRNAs might be differentially expressed yet not significantly alter global 
miRNA expression profiles. To identify differentially expressed miRNAs in the brain, thorax, 
digestive tract and abdomen of dilp2-3,5 flies, we used the Bioconductor package DESeq 
(Anders and Huber, 2010). For the detection of differentially expressed miRNAs, this package 
uses a negative binominal distribution and a shrinkage estimator for the distribution's variance 
to test for differential expression. In the brain and in the thorax significance of differential 
expression was supported by multiple testing. Considering this test, in the brain 2 miRNAs 
were up-regulated and 3 down-regulated (Table 9), while in the thorax, 4 miRNAs were up-
regulated and 15 down-regulated (Table 10). In the digestive tract and abdomen miRNAs 
were differentially expressed but not significant at the significance level of a multiple 
comparison test. As tested by single comparisons one miRNA was up-regulated in the 
digestive tract (Table 11), while in the abdomen 3 miRNAs were up-regulated and one was 
down-regulated (Table 12). Thus, miRNAs were differentially expressed in dilp2-3,5 tissues.   
Brain 
miRNA Mean wt Mean dilp2-3,5 FC p-value p-value 
(adjusted) 
dme-miR-4911-3p 193.90 91.21 0.47 7.28 x 10-5 0.01 
dme-miR-980-5p 296.92 156.47 0.53 7.96 x 10-5 0.01 
dme-miR-986-5p 10211.99 6201.73 0.61 0.00003 0.02 
dme-miR-92a-5p 1913.62 3855.52 2.01 4.8 x 10-7 0.0002 
dme-miR-375-3p 1400.82 5411.37 3.86 2.06 x 10-6 0.0004 
 
Table 9: Differentially expressed miRNAs in dilp2-3,5 brains as detected by next generation 
sequencing. Mean represents miRNA expression in three independent replicates each genotype. 
Fold changes are calculated by DeSeq algorithm. p-values are calculated by Student's t-test and 
adjusted by Benjamini-Hochberg procedure. FC, fold change; wt, wild type 
 
Thorax 
miRNA Mean wt Mean dilp2-3,5 FC p-value p-value 
(adjusted) 
dme-miR-929-5p 353.71 38.89 0.11 1.41 x 10-07 2.37 x 10-05 
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dme-miR-219-3p 37.16 4.33 0.12 0.0002 0.006 
dme-miR-9b-3p 99.14 16.60 0.17 2.17 x 10-05 0.001 
dme-miR-14-3p 217439.69 37063.70 0.17 4.43 x 10-08 1.49 x 10-05 
dme-miR-998-3p 62.62 11.22 0.18 0.0002 0.005 
dme-miR-277-5p 594.03 124.79 0.21 1.04 x 10-06 0.0001 
dme-miR-33-3p 281.87 61.55 0.22 3.88 x 10-05 0.002 
dme-let-7-3p 496.89 111.23 0.22 6.74 x 10-05 0.002 
dme-miR-317-5p 5848.93 1486.28 0.25 5.93 x 10-05 0.002 
dme-miR-33-5p 15512.60 4130.58 0.27 3.17 x 10-05 0.002 
dme-miR-981-3p 269.10 75.00 0.28 0.0005 0.01 
dme-miR-988-3p 107.33 30.29 0.28 5.75 x 10-05 0.002 
dme-miR-274-5p 3038.69 1053.38 0.35 0.001 0.02 
dme-miR-927-5p 581.19 201.82 0.35 0.0009 0.02 
dme-miR-9c-5p 16398.16 5749.61 0.35 0.001 0.02 
dme-miR-1010-3p 676.09 1807.25 2.67 0.001 0.03 
dme-miR-124-5p 43.48 132.16 3.04 0.002 0.04 
dme-miR-1016-5p 14.44 62.94 4.36 0.0003 0.007 
dme-miR-316-3p 76.45 691.14 9.04 4.34 x 10-06 0.0004 
 
Table 10: Differentially expressed miRNAs in dilp2-3,5 thoraces as detected by next generation 
sequencing. Mean represents miRNA expression in three independent replicates each genotype. 
Fold changes are calculated by DeSeq algorithm. p-values are calculated by Student's t-test and 
adjusted by Benjamini-Hochberg procedure. FC, fold change; wt, wild type 
 
Digestive tract 
miRNA Mean wt Mean dilp2-3,5 FC p-value p-value 
(adjusted) 
dme-miR-312-3p 1.04 21.60 20.75 0.005 > 0.99 
 
Table 11: Differentially expressed miRNAs in dilp2-3,5 digestive tracts as detected by next generation 
sequencing. Mean represents miRNA expression in three independent replicates each genotype. 
Fold changes are calculated by DeSeq algorithm. p-values are calculated by Student's t-test and 
adjusted by Benjamini-Hochberg procedure. FC, fold change; wt, wild type 
 
Abdomen 
miRNA Mean wt Mean dilp2-3,5 FC p-value p-value 
(adjusted) 
dme-miR-10-5p 36310.82 20477.72 0.56 0.03 > 0.99 
dme-miR-133-3p 155.46 297.28 1.91 0.01 > 0.99 
dme-miR-263b-5p 3948.61 8055.09 2.04 0.04 > 0.99 
dme-miR-87-5p 27.39 66.44 2.43 0.02 > 0.99 
 
Table 12: Differentially expressed miRNAs in dilp2-3,5 abdomen as detected by next generation 
sequencing. Mean represents miRNA expression in three independent replicates each genotype. 
Fold changes are calculated by DeSeq algorithm. p-values are calculated by Student's t-test and 
adjusted by Benjamini-Hochberg procedure. FC, fold change; wt, wild type 
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2.4.9 qRT-PCR analysis of differential expressed microRNAs 
In order to verify differentially expressed miRNAs in dilp2-3,5 brain and thorax, qRT-PCR on 
selected miRNAs was performed. Independent biological samples were used. In agreement 
with sequencing results, up-regulation of miR-92a-5p in dilp2-3,5 brains was detected, 
although it was not significant (Figure 2.20). However, differential expression of selected 
miRNAs in thorax and for two of three tested miRNAs in the brain was not detected by    
qRT-PCR. Thus, only differential up-regulation of miR-92a-5p in dilp2-3,5 brains could be 
confirmed by qRT-PCR analysis.  
 
Figure 2.20: qRT-PCR analysis verifies differential expression of miR-92a-5p in dilp2-3,5 brains as 
detected by next-generation sequencing. Fold change in (A) brain and (B) thorax from next-generation 
sequencing and qRT-PCR analysis are compared. Differential expression of miR-92a-5p as detected 
by sequencing was verified by tendency of up-regulation as measured by qRT-PCR. miRNA transcript 
level was normalized to wild type samples, which by default was set to 1. * p<0.05, ** p<0.01; *** 
p<0.001, Benjamini-Hochberg test. 
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2.5 Comparison of microarray with next-generation sequencing data 
2.5.1 Comparison of absolute expression datasets between next-generation sequencing 
fand microarrays 
To assess whether the miRNA next generation sequencing data were consistent with the 
miRNA microarray data, correlation between absolute expression profiles of all tissues of 
wild type flies was examined by comparing sequencing density to expression metrics from 
microarray intensities. Raw data were normalized to total number of reads or quantile 
normalization, respectively, to obtain absolute expression profiles. To exclude miRNAs that 
were not detected by either microarray or sequencing, miRNAs with an expression value > 15 
or with less than 10 sequencing reads were filtered out, respectively. The congruency between 
sequencing and microarray expression data was relatively low (Figure 2.21 A). Pearson 
coefficients varied between 0.46 for thorax libraries and 0.56 for brain libraries.   
There can be several reasons for the difference between the sequencing and microarray data. 
The differences could be caused by the use of total RNA for microarrays while for sequencing 
miRNAs were isolated by gel purification ahead of library preparation. Furthermore, for both 
techniques different RNA samples were used, thus biological variation may account for the 
low correlation between sequencing and microarray profiles. Also, the fact that sequencing 
and microarrays are different detection techniques may account for the differences in the 
expression data. To experimentally differentiate whether low correlation of both datasets was 
due to differences in miRNA isolation, biological variation or due to technical reasons 
between the two platforms, we used the same RNA, which was used for sequencing also for 
hybridization to microarrays. Although we used the same gel purified miRNA source, the 
congruency between microarray and next generation sequencing data was not significantly 
increased (Pearson coefficient of 0.5). However, when we compared this newly generated 
microarray data with the microarray data that were generated from total RNA, we observed 
strong correlation between the two datasets (Pearson coefficient 0.9, Figure 2.21 C). 
Therefore, biological variation between samples and miRNA purification methods were not 
underlying the differences in absolute expression between sequencing and microarrays, and 
these differences are most likely caused by technical differences between the two platforms. 
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Figure 2.21: Comparison of wild type absolute expression data of microarrays and next generation 
sequencing. (A) Comparison of expression data in brain, thorax, digestive tract and abdomen as 
detected by microarray hybridized with total RNA and sequencing of libraries generated from isolated 
small RNA. Pearson correlation coefficient of fold change data was computed. (B) Comparison of 
expression of sequencing datasets and datasets from microarrays hybridized with the same isolated 
RNA as used for sequencing. Using the same RNA for both platforms does not increase correlation. 
(C) Comparison of datasets from microarrays hybridized with total RNA and isolated RNA show 
strong correlation. r = Pearson correlation coefficient. 
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2.5.2 Analyzed microRNAs have different calculated hybridization affinities to 
 microarray chips 
One technical difference between sequencing and microarrays is that the latter is based on 
hybridization affinity of miRNAs to complementary sequences on microarrays.  Hybridization 
affinity does not only depend on sequence similarity but also on the melting temperature (Tm) 
of the miRNAs and therefore might be affected by the temperature used during the microarray 
hybridization step. As the GC content varies between miRNAs, we calculated and compared 
Tms of individual miRNAs that had probe sets on the chip (see supplemental table 2). The 
mean calculated Tm of those miRNAs was 57.64 °C but several miRNAs had a Tm over      
65 °C or under 50 °C respectively. The temperature used for the hybridization step was 48 °C. 
Tm is the approximated temperature when half of the molecules are bound to complementary 
sequences on the chip. At temperatures below Tm binding of non-specific miRNAs is 
increased, at temperatures higher than Tm less miRNAs bind to complementary sequences of 
the correspondent probe set. It is likely that miRNAs with low Tm bind to their corresponding 
probe sets at 48 °C with lower affinity than miRNAs with high Tm, and that miRNAs with 
high Tm are prone to bind to non specific probe sets. This might interfere with quantification 
of absolute expression levels. 
2.5.3 Comparison of differential expression datasets between sequencing and 
 microarrays  
Although normalized absolute expression data between sequencing and microarrays showed 
low correlation, both platforms might give similar results when analyzing differential 
expression between wild type and dilp2-3,5 tissues. To test this hypothesis we compared 
differential expression measurements between both platforms. However, fold changes of 
miRNA expression as detected by sequencing did not correlate with differential expression as 
detected by microarray (Pearson coefficient between 0.24 for abdomen and -0.38 for thorax, 
Figure 2.22 A). To assess whether biological differences account for the discrepancy in fold 
change detection of genotypes, we compared fold changes as detected by microarray with fold 
changes as detected by sequencing using the same RNA input. When using the same 
biological sample, the fold changes of both techniques showed strong correlation with a 
Pearson coefficient of 0.82 (Figure 2.23 B). In contrast, a Pearson coefficient of -0.4 for the 
comparison of two microarray datasets which were generated using different biological RNA 
samples showed no correlation of fold changes (Figure 2.23 C), suggesting that the 
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differences in differential expression between microarray and next generation sequencing data 
is caused by biological variation between samples. 
 
Figure 2.22: Comparison of fold change data as detected by microarrays and next generation 
sequencing. (A) Comparison of fold change data in brain, thorax, digestive tract and abdomen as 
detected by microarray hybridized with total RNA and sequencing of libraries generated from isolated 
small RNA. Pearson correlation coefficient of fold change data was computed and revealed low 
correlation (B) Comparison of fold change of sequencing datasets and datasets from microarrays 
hybridized with the same isolated RNA as used for sequencing. Using the same RNA for both 
platforms revealed strong correlation (C) Comparison of datasets from microarrays hybridized with 
total RNA and isolated RNA show low correlation. r = Pearson correlation coefficient. 
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2.5.4 Correlation between expression level and fold change in differentially expressed 
fmicroRNAs  
Differential expression of lowly expressed miRNAs is prone to be affected by small 
aberrations in expression. Accordingly, small variations in expression do not considerably 
contribute to expression differences of strongly expressed miRNAs. In order to investigate 
whether correlation of fold changes between microarray and sequencing of strongly expressed 
miRNAs is higher than of lowly expressed miRNAs, miRNA expression level as detected by 
microarray was color labeled in the comparison of differential expression between microarray 
and sequencing (Figure 2.23). Indeed, low expressed miRNAs showed the strongest fold 
change difference between experiments. Therefore, fold changes of lowly expressed miRNAs 
might be an artefact generated by small variations in expression and not caused by genotype.  
 
 
Figure 2.23: MiRNAs, which are expressed at low levels, show higher variation in fold change 
between microarrays and next-generation sequencing. Comparison of fold change data as detected 
by microarrays and next generation sequencing in brain, thorax, digestive tract and abdomen. 
Microarrays were hybridized with total RNA and next-generation sequencing libraries were generated 
from isolated small RNA. Degree of absolute expression in microarrays is depicted color-coded.  
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In summary, absolute expression levels were dependent on the technical platform used for 
analysis, whereas fold change differences were more affected by variation between different 
biological samples. MiRNAs that were detected to be expressed at low levels account for the 
majority of miRNAs which were detected to be differentially expressed. 
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3 Discussion 
3.1 Next generation sequencing of Drosophila tissues 
I used next generation sequencing to generate tissue-specific miRNA expression profiles of 
adult wild type and dilp2-3,5 mutant Drosophila flies. In a first test library, which was 
isolated by a standard column fractionation protocol, most reads mapped to ribosomal RNA, 
particularly 2S rRNA. With a size of 30 nucleotides Drosophila 2S rRNA is very similar in 
length to miRNAs and therefore column fractionation was not sufficient to remove 2S rRNA 
from the library. In addition, 2S rRNA is expressed at very high levels compared to miRNAs, 
which explains the high number of reads mapping to 2S rRNA and the low number of 
miRNAs detected in the test library. In order to optimize library preparation, I tested three 
different miRNA enrichment methods, (A) gel purification, (B) oligo-depletion of 2S rRNA 
and (C) a combination of A and C. Gel purification of miRNAs was more efficient than oligo-
depletion in removing 2S rRNA from the library and the combination of both methods did not 
improve the enrichment of miRNA significantly beyond gel purification alone. Therefore, all 
next generation sequencing of adult Drosophila miRNAs was done using gel purification of 
miRNAs as input for library preparation. By this method the amount of sequences that 
mapped to rRNA was reduced to 4-6 % in the brain, thorax and abdomen and to 17 % in the 
digestive tract. With an average of 12 million the number of reads per library mapping to 
miRNAs was very high. Although libraries from the digestive tract contained four times less 
miRNA reads than the libraries of the other tissues, in all libraries the amount of reads that 
mapped to Drosophila miRNAs, was sufficient for analysis. Three replicates were used for 
each condition and miRNA read counts were reproducible within independent biological 
replicates. 
In the digestive tract only 16 % of all reads mapped to Drosophila miRNAs, which is 
significantly less than in the other tissues, where 70-80 % of all reads mapped to miRNAs. 
Furthermore, 67 % of the reads of the digestive tract library did not map to any Drosophila 
sequence. The digestive tract differs from the other tissues in the fact, that it contains the food 
the fly is eating but also serves as a habitat for the gut microbiota (Wong et al., 2011). Yeast 
is a main component of the fly food and alignment of the reads to the yeast genome showed 
that more than 30 % of all reads of the digestive tract libraries mapped to yeast sequences. 
Thus, the high amount of reads not mapping to Drosophila sequences in the digestive tract 
libraries is at least partially due to small yeast RNAs. Whether these small yeast-derived 
RNAs have any functional role in Drosophila or are just degradation products of digestion is 
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currently unknown. Interestingly, in humans and various animals cross-species regulation of 
gene expression by miRNAs taken up with the food have been reported. For example, mir-
186 is a very abundant miRNA in rice that was shown to be enriched in the blood serum of 
Chinese people. In mice, rice mir-186 was able to regulate expression of the low-density 
lipoprotein receptor adaptor protein 1, demonstrating that a plant-derived miRNA can regulate 
gene expression in mammals (Zhang et al., 2012). However, as miRNAs are not annotated in 
yeast, it is currently unknown whether these yeast-derived RNAs have similar function in 
flies. 
The wild type and dilp2-3,5 mutant flies used in this study both carry the endosymbiontic 
bacterium Wolbachia pipientis. Accordingly, reads mapping to the genome of Wolbachia 
were identified in all analyzed tissues, ranging from 0.4 % of all reads in the brain up to 1.8 % 
of all reads in the abdomen. Even though the detailed molecular interaction between 
Wolbachia and its host are still elusive, dilp2-3,5 mutants are only long-lived in the presence 
of this bacterium (Grönke et al., 2010). Interestingly, the amount of reads mapping to the 
Wolbachia genome is increased in dilp2-3,5 flies. This is in agreement with the observation, 
that in dilp2-3,5 flies the amount of Wolbachia bacteria is increased (Sebastian Grönke, 
personal communication). The influence of increased Wolbachia load in dilp2-3,5 flies is still 
elusive. In mosquitos, Wolbachia changes the expression of host miRNAs to increase its 
density in the host (Hussain  et al., 2011). Profiling and comparing miRNA expression of 
dilp2-3,5 mutants with and without Wolbachia could explore a putative role of  Wolbachia in 
the regulation of miRNA expression in dilp2-3,5 flies.  
 
3.2 Comparison of absolute expression datasets between sequencing and 
microarrays 
I could show in this study that absolute miRNA expression data between microarray and next 
generation sequencing only show low level of correlation between the two platforms. This 
was also evident on the level of individual miRNAs. For example, miR-14 was one of the 
strongest expressed miRNAs as detected by sequencing, but miR-14 was not detected at all by 
microarray analysis. Using the same RNA source for both platforms did not increase 
correlation of absolute expression values. In contrast, two microarray expression datasets 
from independent biological RNA samples showed strong correlation, demonstrating that the 
observed differences are not caused by biological variation between samples. Therefore, 
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differences in absolute expression data between the two platforms are likely caused by 
differences between microarray and next generation sequencing technologies. One technical 
difference might be hybridization bias of microarrays, which can have several reasons. First, 
hybridization affinity of miRNAs on the microarrays is dependent on the similarity to the 
complementary sequence of the probe set. Many miRNAs share high sequence similarities. 
For example miR-2a and miR-2c mature miRNAs only differ in a single nucleotide. Thus, 
differences between miRNA expression data might be due to miRNAs binding to probe sets 
of closely related miRNAs. Second, the Affymetrix 2.0 GeneChip used in this study contains 
probe sets for more species in addition to the Drosophila melanogaster probe sets. Thus, 
miRNAs may bind these non-Drosophila melanogaster probe sets, which could affect their 
absolute expression levels. Third, the GC content varies substantially among miRNAs 
resulting in different melting temperatures for each miRNA. As hybridization temperature is 
constant, miRNAs with low melting temperatures might bind to the chip with lower affinity 
while others with high melting temperatures bind with high affinity. Thus differences between 
miRNA expression data might be caused by different GC content and consequently different 
affinity of miRNAs in binding to complementary sequences on the chip. Library preparation 
for next generation sequencing might also introduce expression bias for certain miRNAs. In a 
comparison of different miRNA profiling methods Linsen et al. (Linsen et al., 2009) 
observed, that different methods for miRNA library preparation caused differences in absolute 
expression profiles for specific miRNAs. Biases caused by RNA ligation preferences, reverse 
transcriptase and PCR amplification could also contribute to the difference between 
microarrays and sequencing in the ability to detect absolute expression levels of miRNAs in 
our study. It has been shown that it is not possible to conclude from detection signal of 
microarrays to biological expression levels (Chen et al., 2009). The results of my study are in 
agreement with the observation that absolute miRNA expression measurements are dependent 
on the used detection technique. NGS can distinguish between very similar sequences, which 
differ only in a single nucleotide. Additionally, since NGS is not dependent on a priori 
information it allows the detection of unknown miRNAs as well as miRNA isoforms resulting 
from post-transcriptional modification. Additionally, it allows the detection of more miRNAs 
than by microarray. Therefore, further studies should be based on sequencing results. 
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3.3 Adult Drosophila microRNA expression atlas 
The function of most Drosophila miRNAs is still unknown. An important step in 
comprehending miRNA function is to understand miRNA tissue specificity. However, for 
most Drosophila miRNAs adult expression level and tissue specificity are still elusive. To 
close this gap we generated miRNA expression profiles of four adult Drosophila tissues, 
namely brain, thorax, digestive tract and abdomen, by microarray and next generation 
sequencing. 
3.3.1 Tissue-specific microRNA expression profiles 
Pairwise comparison of miRNA expression profiles of the four tissues confirmed that the 
quality of tissue preparation was constant and indicated that each tissue inhered a unique and 
characteristic miRNA expression pattern. Tissue specificity from sequencing and microarrays 
were mostly consistent between both platforms as revealed by Pearson correlation analysis. 
We identified ubiquitously expressed miRNAs and many miRNAs that are expressed 
specifically in a certain tissue. Most miRNAs with a high tissue specificity score were 
expressed in the brain. This could indicate that particularly brain function is highly 
specialized and needs to be regulated by specific miRNAs. However, this could also represent 
the purity of dissected brains. 
3.3.2 Tissue specificity of microRNAs is in agreement with published data  
Our Drosophila miRNA atlas is in agreement with published data. miRNAs like miR-981, 
miR-969, miR-927 or miR-990 were shown to be expressed in Drosophila heads (Ruby et al., 
2007). Accordingly, we found these miRNAs to be specifically expressed in the brain. 
Neuronal expression of miR-124 is evolutionarily conserved between flies, nematodes, and 
vertebrates and a function of miR-124 in Drosophila neurons has been reported (Sun et al., 
2012). In agreement, we found specific expression of miR-124 in the brain. Another brain-
specific miRNA, miR-219, was shown to be specific for brain cells in vertebrates, and to 
control oligodendrocyte differentiation (Zhao et al., 2010). In contrast to the analysis of total 
head miRNA expression (Ruby et al., 2007), our analysis detected expression more precisely 
in the brain and in addition identified up to now unknown brain specificity for some miRNAs. 
For example, miR-315 was found to be specifically expressed in fly imaginal discs (Ruby et 
al., 2007), but we could show specific expression of miR-315 in the adult brain. Data about 
tissue specificity of novel miRNAs is still limited. Our study provides detailed information 
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about tissue specificity of novel miRNAs such as miR-4960, which we assigned to be a brain 
specific miRNA.  
miR-1 has been shown in diverse species including Drosophila to be specifically expressed in 
muscles (Zhao et al., 2007; Simon et al., 2008; Sokol and Ambros, 2005). In our study miR-1 
expression was enriched in the thorax, although with a relative low tissue-specificity score 
compared to the brain-specific miRNAs. Similarly, miR-277 was previously shown to be 
expressed in the thorax (Esslinger et al., 2013), which we could verify in our analysis. 
However, as for miR-1, the tissue specificity score was relatively low. The dissected thorax 
does not only consist of muscle tissue, but also includes epidermal tissue, fat tissue and parts 
of the nervous system. Different tissues types in thorax samples might limit the detection of 
specificity. Indeed, only few miRNAs had a high tissue specificity score for the thorax. 
miRNAs like miR-314, miR-958 or miR-956 were previously shown to be expressed in adult 
fly bodies (Ruby et al., 2007). Our study shows that these miRNAs are not ubiquitously 
expressed throughout the whole adult fly, but specifically in the digestive tract. Another 
example for a digestive tract-specific miRNA is miR-10. During embryogenesis miR-10 is 
expressed in the posterior midgut and the anal pad (Aboobaker et al., 2005) and we show that 
in the adult, expression of miR-10 remains specific for the digestive tract. miR-2494,        
miR-1015, miR-994 and miR-274 are examples of miRNAs, which expression was previously 
detected in whole adult bodies (Ruby et al., 2007) and we could now show that they are 
specifically expressed in abdomen. In summary, the observed tissue-specific miRNA 
expression profiles are consistent with previous reports and significantly extend our 
knowledge about miRNA expression in adult Drosophila flies. 
Expression and function of miR-993 was unknown so far. miR-993 belongs to the well 
characterized and conserved miR-10 miRNA family. miR-10 is one of two miRNA genes of 
the Drosophila Hox clusters and it has been shown to be expressed in ventral nerve cord, 
posterior midgut and hindgut in Drosophila embryos (Aboobaker et al., 2005). miR-10 was 
shown to regulate Hox genes in zebrafish (Woltering and Durston, 2008) and humans (Han et 
al., 2007). However, in Drosophila the targets of miR-10 are unknown. Although miR-993 
belongs to the miR-10 family, it is not predominantly expressed in the gut. Instead, it is 
expressed in the thorax and also to a minor extent in the brain, suggesting that its function is 
different to miR-10. Therefore, miRNAs which belong to the same miRNA family do not 
necessarily have same expression patterns. 
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3.3.3 Strong microRNA expression increases reliability in the detection of                
 dtissue specificity  
For few miRNAs tissue specificity differs between microarrays and sequencing. miRNAs, 
which were determined as tissue-specific by microarray but not by sequencing, are usually 
expressed at low levels as detected by sequencing and high levels as detected by microarray. 
For example miR-184-5p had a strong signal on microarrays, whereas by sequencing this 
miRNA had only few reads. Reciprocally, miRNAs, which were determined to be tissue-
specific by sequencing, but not by microarray are barely detected by microarrays, but detected 
to be highly expressed by sequencing. For example miR-958-3p had a high number of reads 
in the digestive tract whereas this miRNA was not detected by microarray analysis to be 
tissue-specific. Thus, assigning tissue specificity to a miRNA can depend on the platform 
used to detect its expression and is more reliable if the miRNA expression is detected at 
significant levels on both platforms.  
3.3.4 Evolutionary conservation of microRNAs does not correlate with breadth of 
dexpression  
Evolutionary conserved miRNAs were more ubiquitously expressed across libraries of 
different Drosophila developmental stages, heads and adult bodies than non-conserved 
miRNAs (Ruby et al., 2007). In contrast, we found no correlation between evolutionary 
conservation of miRNAs and breadth of expression across tissues of adult Drosophila flies. 
Non-conserved miRNAs might define profile specificity only of developmental stages but not 
of adult tissues. However, our finding could also reveal that there is indeed no correlation 
between tissue specificity and conservation level of a miRNA in adult flies. 
3.3.5 Evolutionary conservation of microRNAs correlates with expression level 
Highly expressed miRNAs tend to be more evolutionarily conserved than miRNAs with low 
expression levels (Ruby et al., 2006; Ruby et al., 2007; Bartel, 2004). In agreement with this 
hypothesis, we also found a positive correlation between expression level and evolutionary 
conservation in our next generation sequencing data set. However, some miRNAs deviate 
from this rule, e.g. miR-956 is only present in Drosophila but highly expressed. On the other 
hand, expression level of some conserved miRNAs might be underestimated due to a very 
tissue- or cell type-specific expression. These miRNAs would have low read counts in 
libraries of complex tissues samples. For example, miR-285 was found to be expressed at low 
levels  in all analyzed tissues although it belongs to the conserved miR-29 family. In 
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mammals, miR-29 expression is enriched in astrocytes (Ouyang et al., 2013). Astrocyte-like 
glia account for a subset of brain cells in Drosophila and other cells of the dissected brain 
may mask high astrocyte-specific expression of miR-285. Like miR-285, other conserved 
miRNAs, which were found to be lowly expressed could be restricted to a certain tissue or 
cell type not analyzed in this study. Although sequencing analysis revealed a clear correlation 
between miRNA expression level and evolutionary conservation, no correlation was observed 
using microarrays. On the Affymetrix microarray only a limited number of miRNAs are 
present, excluding many miRNAs with low expression. Sensitivity of microarrays might be 
limiting, whereas sequencing was able to detect a non-random correlation between expression 
level and evolutionary conservation.  
3.4 Differentially expressed microRNAs in dilp2-3,5 mutants 
In Drosophila, tissue-specific down-regulation of IIS signaling is sufficient to increase 
lifespan (Grönke et al., 2010; Giannakou et al., 2004; Hwangbo et al., 2004; Demontis and 
Perrimon, 2010). However, it is currently unknown whether miRNAs mediate pathway 
activity and gene expression downstream of the insulin receptor. We identified differentially 
expressed miRNAs in all four analyzed tissues of the dilp2-3,5 mutant by microarray analysis 
and confirmed the expression changes for selected miRNAs by qRT-PCR. qRT-PCR analysis 
also showed that miRNAs such as miR-2500-5p and miR-986-5p, which by microarray 
analysis were only found to be regulated in the brain and thorax, were also differentially 
regulated in the digestive tract and the abdomen. These results suggest that the sensitivity of 
microarrays may be limiting for some miRNAs to detect differential expression and 
demonstrates that qRT-PCR verification is important. Some miRNAs were found to be up-
regulated in one tissue and down-regulated in other tissues, demonstrating complex tissue-
specific changes in miRNA expression upon down-regulation of the IIS pathway. The number 
of miRNAs that were up- and down-regulated was comparable in the brain and in the 
abdomen. In the digestive tract most miRNAs were down-regulated and in the thorax most 
miRNAs were up-regulated in dilp2-3,5 mutants. This observation was independent of the 
tissue preparation method and the microarray chip version and was reproducible, because it 
was observed for both mechanically and manually dissected thoraces. Less miRNAs were 
detected to be differentially expressed in manually dissected thoraces due to variation in 
samples, which affects the sensitivity to detect differentially expressed miRNAs.  
By sequencing of independent biological tissue samples we found a different set of miRNAs 
to be up- and down-regulated than by microarray. In the brain and in the thorax miRNAs were 
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found to be significantly differentially expressed. At the significance level of single 
comparisons, differentially expressed miRNAs were also found in the abdomen and digestive 
tract. In contrast to microarray results, we found the majority of differentially expressed 
miRNAs in the thorax to be down-regulated. Malone and Oliver (Malone and Oliver, 2011) 
reported that sequencing and microarrays show similar performance in detecting differential 
mRNA expression. We could show that the detection of differentially expressed miRNAs in 
dilp2-3,5 mutants correlated only if the same RNA input was used for both techniques. 
Comparison of differential expression of microarray and sequencing data using independent 
RNA samples showed no correlation. Thus, detection of differential expression levels in 
dilp2-3,5 mutants is independent of the technique used though only consistent when the same 
RNA is used for both techniques. miRNAs with the strongest fold change in expression were 
usually detected at low levels. The signal of differentially expressed miRNAs like miR-303-
5p was even close to the detection threshold. Strongly expressed miRNAs are usually 
evolutionary conserved and the expression was less changed in the mutant than the expression 
of low expressed miRNAs. One possible explanation is that conserved miRNAs could execute 
essential functions and are therefore under stringent control to keep constant expression 
levels. Another explanation is that the fold change of barely expressed miRNAs is caused by 
variations in expression attributable to the  influence of small variations on FC of low 
expressed miRNAs. This could account for the different results of microarray, sequencing and 
qRT-PCR in the detection of differentially expressed miRNAs using independent biological 
samples.  
3.4.1 MicroRNA candidates and their role in regulation of lifespan 
The function of most miRNAs that were detected as differentially expressed in dilp2-3,5 
mutants is not known in Drosophila or any other species. However, some of those miRNAs 
have been shown to play a role in aging or aging-modulating pathways.  
miR-210 is highly evolutionarily conserved between flies and mammals. In mammals,      
miR-210 is induced by hypoxia and is a direct targeted of the hypoxia-inducible factor    
(HIF-1α) (Liu et al., 2011), a transcription factor involved in lifespan regulation. 
Interestingly, HIF-1α is activated by the insulin pathway in Drosophila (Dekanty et al., 2005). 
Thus, it would be expected that miR-210 abundance is reduced in dilp2-3,5 mutants. In 
contrast, we showed by microarray that miR-210 is up-regulated in dilp2-3,5 flies. This might 
indicate an inherent compensatory effect. However, to discover the role of elevated miR-210 
levels in dilp2-3,5 mutants, functional analysis of this miRNA in Drosophila is required.  
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miR-285 is down-regulated in dilp2-3,5 mutants. Drosophila miR-285 belongs to the 
conserved miR-29 family. In mammals, upregulation of miR-29 correlates with aging and 
miR-29 is up-regulated in a progeroid mouse model most likely in response to DNA damage 
(Ugalde et al., 2011). The function of Drosophila miR-285 is not known, yet. However, if the 
function of miR-29 is conserved, dilp2-3,5 mutants might have less DNA damage, which in 
consequence results in the down-regulation of miR-285. Further studies are needed to test this 
hypothesis. 
miR-375 expression was found to be up-regulated in dilp2-3,5 brains by sequencing. miR-375 
is highly evolutionarily conserved and its function has been extensively characterized.      
miR-375 is specifically expressed in secretory pituitary brain cells in zebrafish (Kapsimali    
et al., 2010). In mammals, miR-375 is specifically expressed in pancreatic islets (Poy et al., 
2009), where it is involved in regulation of glucose homeostasis. miR-375 knockout mice are 
hyperglycemic, have decreased numbers of pancretic β-cells and reduced insulin levels (Poy 
et al., 2009). Furthermore, in obese mice, which are insulin resistant and have an increased 
insulin demand, miR-375 is up-regulated to compensate this state by promoting β-cell 
expansion (Poy et al., 2009). The function of Drosophila miR-375 is currently unknown. 
However, its role in glucose homeostasis in mammalian pancreatic cells, and its differential 
expression in dilp2-3,5 flies, might indicate a role of miR-375 in Drosophila insulin 
producing cells (IPCs).  
Our sequencing analysis reveals that miR-33 is down-regulated in the thorax of dilp2-3,5 
mutant flies. miR-33 is evolutionarily conserved and in mammals it targets the insulin 
receptor substrate 2 (IRS2) in liver cells (Dávalos et al., 2011). Overexpression of miR-33 not 
only reduces IIS, it also reduces fatty acid oxidation, whereas reduction of miR-33 increases 
both pathways (Dávalos et al., 2011). Furthermore, miR-33 was shown to regulate cholesterol 
levels in mice (Rayner et al., 2010). miR-33 might be a putative regulator of metabolic 
pathways in the fly, since dilp2-3,5 flies have altered lipid levels. However, so far miR-33 
was not functionally characterized in Drosophila and it role in IIS or fatty acid metabolism 
needs to be further investigated. 
miR-277, which is specifically expressed in the thorax was down-regulated in dilp2-3,5 
mutant flies. We could show that overexpression of miR-277 in fly thoraces shortens lifespan, 
which would suggest down-regulation of miR-277 as a putative mechanism of IIS-mediated 
lifespan extension. However, inhibition of miR-277 also shortens lifespan in flies and       
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miR-277 has been reported to be down-regulated with age (Esslinger et al., 2013). Thus the 
role of miR-277 in IIS-dependent lifespan extension is currently unclear. 
let-7 miRNA is highly evolutionarily conserved between species including worms, flies and 
mammals. In mammals let-7 was shown to target components of the insulin pathway 
including insulin-like growth factor 1 receptor (IGF1R), insulin receptor (INSR) and IRS2 
(Zhu et al., 2011). In worms let-7 family members miR-84 and miR-241 were also shown to 
regulate insulin/IGF signaling and metabolism. Additionally, these two miRNAs are required 
for germline mediated longevity through DAF-16/FOXO (Shen et al., 2012). let-7 family 
members miR-84 and miR-241 are not annotated in Drosophila or more complex species. let-
7-3p was shown to be down-regulated in dilp2-3,5 thoraces as detected by sequencing. 
However, this miRNA is lowly expressed and there is no evidence that it has a biological 
function. let-7-5p is highly expressed, its expression was validated by northern blot and its 
function was characterized (Sokol et al., 2008). In contrast to let-7-3p let-7-5p was not 
detected to be differentially regulated in dilp2-3,5 flies suggesting that the conserved miRNA 
let-7 might not regulate IIS mediated phenotypes in Drosophila.  
miR-14 was shown to control insulin production in IPCs in the fly brain. Overexpression of 
miR-14 in the IPCs resulted in lean flies possibly as consequence of elevated insulin levels. 
Similar to IIS mutants, miR-14 mutants have elevated fat levels. Furthermore, dILP2, dILP3 
and dILP5 levels in the brain are decreased in miR-14 mutants (Varghese et al., 2010).      
miR-14 expression was not only detected in the brain, but also in all other analyzed tissues. 
We found miR-14 to be down-regulated in dilp2-3,5 thoraces. Since miR-14 was shown to 
regulate dILP levels and we showed that miR-14 expression in turn is dependent on dILPs, 
this miRNA could be part of a feedback loop regulating IIS. Interestingly, miR-14 was 
reported to play a role in the positive autoregulatory loop of ecdysone signaling (Varghese 
and Cohen, 2007), a pathway which was shown to play a role in lifespan (Gáliková et al., 
2010). Further studies are needed to address the regulatory role of miR-14 in endocrine 
signaling and its putative connection to lifespan.   
If differentially expressed miRNAs contribute to phenotypes of the dilp2-3,5 mutant remains 
to be investigated. By microarray and sequencing in each tissue of the long-lived dilp2-3,5 
mutant differentially regulated miRNAs which are highly conserved even up to humans were 
found. Since many molecular mechanisms of IIS are similar between organisms, a 
comparison of our data with tissue-specific  miRNA expression profiles of long-lived mutants 
from other organisms could provide information about conserved regulation of miRNAs in 
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processes associated with IIS-mediated phenotypes such as longevity. As Drosophila provides 
excellent genetic tools to study the role of miRNAs in aging in vitro and in vivo, studies in 
this model organism could provide new insights into mechanisms, which could be relevant for 
other organisms. 
3.4.2 The microRNA 6~309 cluster is up-regulated in dilp2-3,5 abdomen 
Tissue specificity of dilp2-3,5 miRNAs is altered compared to wild type. Interestingly, 
analysis of tissue specificity was able to identify miRNAs, which tissue specificity was 
altered but not significantly differentially expressed. miRNAs with altered tissue specificity 
involve miR-5-5p, miR-286-3p, miR-6-1-3p/miR-6-2-3p/miR-6-3-3p and miR-4-3p. 
Expression of these miRNAs is evenly distributed across tissues in wild type. In dilp2-3,5 
mutants, expression of these miRNAs becomes enriched in the abdomen. It was shown that 
clustered miRNAs are often co-expressed in an operon-like manner (Ruby et al., 2007; Lau et 
al., 2001; Sempere et al., 2004). Indeed, all identified miRNAs are located within the same 
genomic cluster, indicating that these miRNAs are concerted up-regulated in dilp2-3,5 
abdomen. Verification and functional analysis by knock-out or overexpression is necessary to 
unravel the putative role of this cluster in phenotypes of the dilp2-3,5 mutant.  
3.5 The miR-986
KO
 mutant 
In this study a miR-986
KO
 mutant was successfully generated by homologous recombination 
and analyzed for IIS-associated phenotypes. Homozygous miR-986
KO
 mutant flies were viable 
and had no obvious developmental defects, indicating that miR-986 is not essential for 
viability and growth. Moderate overexpression of miR-986 did not affect lifespan. In contrast, 
lack of miR-986 significantly reduces lifespan. Therefore, correct miR-986 expression is 
required for normal lifespan. Fecundity of miR-986
KO
 flies was reduced and mutants were 
prone to starvation, indicating that normal miR-986 expression is required for long term 
health.  
Tolerance towards DDT or hydrogen peroxide was not changed in miR-986
KO 
mutants 
compared to wild type flies. In contrast, miR-986
KO 
mutants were more resistant to paraquat 
treatment. Toxicity of paraquat involves the production of superoxide. Increased paraquat 
resistance of flies lacking miR-986 suggests that miR-986 might target mRNAs responsible 
for superoxide resistance. However, a target prediction algorithm did not reveal genes 
involved in superoxide detoxification. The production of superoxide by reduction of paraquat 
is mainly mediated by P450 oxidoreductases (Han et al., 2006). miR-986 resides within an 
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intron of the P450 cytochrome gene Cyp4e2. Cyp4e2 expression is down-regulated in       
miR-986
KO
 flies. Therefore, increased tolerance of miR-986
KO
 flies to paraquat might be 
caused by a reduced expression of Cyp4e2 and hence reduced generation of superoxide in 
these mutants and not by a direct effect of loss of miR-986.  
To differentiate whether reduced Cyp4e2 or the lack of miR-986 causes the observed 
phenotypes further studies are needed. In order to test whether observed phenotypes can be 
assigned to the lack of miR-986, a miR-986 mutant without white-marker and with rescued 
expression of Cyp4e2 was successfully generated and is available for phenotyping. Further, 
genomic rescue experiments are necessary to study the in vivo function of miR-986.  
3.6 Functional characterization of differentially expressed microRNAs by 
overexpression 
Overexpression of miR-7 and miR-978 during development caused lethality, suggesting that 
misexpression of those miRNAs has toxic effects early in development. Conserved miRNAs 
might execute essential functions and their precise regulation might be pivotal for the 
organism. Although miR-7 is conserved and causes lethality when artificially overexpressed, 
overexpression of the non-conserved miR-978 did also cause lethality. Therefore, toxicity 
upon overexpression is independent on evolutionarily conservation of the overexpressed 
miRNA. miRNAs are expressed at different levels in Drosophila. Upregulation of miRNAs 
that are normally expressed at low levels might have more severe impacts on health than 
upregulation of miRNAs that are highly expressed in wild type flies. Both, miR-7 and      
miR-2500 are expressed at relative low levels. While overexpression of miR-7 causes lethality 
and adult specific expression of miR-7 severely impacts lifespan, miR-2500 overexpressing 
flies are viable. Thus, toxicity of overexpression is independent on the degree of induced 
differential expression. 
Adult specific strong ubiquitous overexpression with the tubulin-Gal4 or tubulin-GS driver of 
most miRNAs resulted in shortened lifespan. This could be a specific effect due to toxicity of 
the particular miRNA, possibly caused by expression in tissues where this miRNA is usually 
not or not as highly expressed resulting in the down-regulation of pivotal genes in these 
tissues. Alternatively, this could be a general effect of increased miRNA load in the cells, 
which becomes toxic over time. Strong overexpression may also affect miRNA target 
specificity so that genes are down-regulated, which are not normally a target of a given 
miRNA. 
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Strong overexpression of candidate miRNAs did not increase lifespan. However, this does not 
exclude that overexpression of other miRNAs could be beneficial for survival. Indeed, mild 
overexpression of miR-34 by genomic insertion constructs increased lifespan, while 
Gal4/UAS mediated expression of miR-34 during development caused lethality (Liu et al., 
2012). By usage of a mild daGS driver, toxicity of overexpression of analyzed miRNAs was 
reduced. A lifespan extending effect of miRNA overexpression could be dosage-dependent 
with strong miRNA expression resulting in toxicity. In congruence, miRNAs in dilp2-3,5 flies 
showed only small differential expression. Overexpression level of miRNAs can be fine tuned 
by the concentration of RU486 in the food. Therefore, miRNA expression that mimic the fold 
change in long-lived mutants were used to investigate lifespan phenotypes. Mild 
overexpression of selected miRNAs prevented toxic effects on lifespan, suggesting that 
toxicity of up-regulation is dosage dependent. However, lifespan was not increased upon 
various levels of mild overexpression, suggesting that ubiquitous up-regulation of the selected 
candidate miRNAs is not beneficial for survival. In dilp2-3,5 flies miRNAs were 
differentially expressed in specific tissues. In order to test whether lifespan depends on tissue-
specific overexpression of selected miRNAs, miR-210, miR-954 and miR-978 were 
overexpressed in specific tissues. Neither overexpression affected lifespan, suggesting that 
selected miRNAs do not mediate lifespan extension. Other miRNAs still could mediate IIS 
dependent lifespan, which were not identified to be differentially expressed by microarray. 
Sequencing revealed a different set of differentially expressed miRNAs in dilp2-3,5 mutants, 
which should be analyzed for their role in lifespan extension.  
Although there is no evidence for differentially expressed miRNAs which were identified by 
microarray to regulate lifespan extension, those miRNAs could play a role in other IIS 
mediated phenotypes and were therefore analyzed for phenotypes of dilp2-3,5 flies. dilp2-3,5 
flies have a reduced body weight, increased development time and reduced fecundity (Grönke 
et al., 2010). However, flies overexpressing miR-986, miR-2500 or miR-954 had normal body 
weight, suggesting that these miRNAs do not regulate organismal growth. Overexpression of 
selected miRNAs reduced egg production. Because increased expression of miRNAs also 
reduced lifespan, it is unlikely that reduced egg production as a result of overexpression is a 
specific effect. Instead, decreased fecundity seems to be an unspecific effect caused by 
toxicity of overexpression. Overexpression of miR-2500 or miR-954 did not change 
development time, suggesting that those miRNAs do not regulate developmental timing. In 
contrast, miR-986 overexpression caused a delay in development. The effect was stronger in 
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males than in females, suggesting gender-specific functions of miR-986. Consistently, 
development time of two of three independent fly strains lacking miR-986 was shortened.  
Further analysis of IIS-related phenotypes of flies overexpressing miRNAs that are 
differentially regulated in dilp2-3,5 flies is needed. Differentially expressed miRNAs should 
also be investigated by knockout or RNAi in order to distinguish between specific and 
unspecific effects and to verify functions in IIS related phenotypes. In addition to the analysis 
of differentially expressed miRNAs that might be putative mediators of IIS depending 
phenotypes, miRNAs that are expected to target components of lifespan modulating pathways 
such as the IIS pathway, should be investigated for longevity by overexpression or down-
regulation in order to explore upstream mechanisms and to get a comprehensive overview of 
the role of miRNAs in lifespan regulating pathways.  
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4 Material and methods 
4.1 Bacterial media 
All bacterial media were autoclaved to assure sterility. Antibiotics were added to media after 
autoclaving and cooling to 60 °C. 
Lysogeny broth (LB) medium    1% NaCl 
        pH 7.0  
        1 % (w/v) Trypton 
        0.5 % yeast extract 
 
Bacterial plates consisted of LB medium with 1.5 % bacto-agar. 
S.O.C medium      20 mM glucose 
        10 mM MgSO4 
        10 mM MgCl2 
        2.5 mM KCl 
        10 mM NaCl 
        0.5 % yeast extract 
        2 % bactotryptone 
4.2 Solutions 
TAE (1x)       40mM Tris  
        20mM acetic acid 
        1mM EDTA 
 
TBE (5x)       445 mM boric acid 
        445 mM Tris 
        10 mM EDTA 
 
PBS        145 mM NaCl 
        7.5 mM Na2HPO4 
        2.5 mM NaH2PO4 
        pH adjusted to 7.4 
 
Squishing buffer      10 mM Tris-HCl  
        1 mM EDTA 
        25 mM NaCl 
        200 µg/ml Proteinase K 
        pH adjusted to 8.2 
 
Saline-sodium citrate buffer (SSC; 20x),  RNAse-free  3 M sodium chloride  
        300 mM trisodium citrate  
        pH adjusted to 7.0 with HCl 
 
MyOne C1 dynabead B&W buffer + 0.01% Tween (2x) 10 mM Tris-HCl (pH 7.5) 
        1 mM EDTA 
        2M NaCl 
        0.01% Tween 
Material and methods 
 
73 
 
 
MyOne C1 dynabead B&W buffer + 0.01% Tween (1x) 5 mM Tris-HCl (pH 7.5) 
        500 µM EDTA 
        1M NaCl 
        0.01% Tween 
 
MyOne C1 dynabead Solution A    0.1 M NaOH 
        0.05 M NaCl 
 
MyOne C1 dynabead Solution B    0.1 M NaCl 
4.3 Drosophila food media 
All Drosophila food and media were boiled to dissolve agar. Nipagin was added to media 
after boiling and cooling to 60 °C. 
SYA food       5 % sugar 
        10 % yeast 
        1.5 % agar 
        0.3 % Nipagin (20 % in EtOH) 
 
Starvation media      1 % agarose in H2O 
H2O2 media       1 % agarose (w/v) 
        5 % H2O2 
        10 % sugar (w/v) 
        in H2O 
 
Dichlorodiphenyltrichloroethane (DDT) media  275 mg/l DDT 
        in SYA food 
 
Paraquat media      20 mM paraquat 
        in SYA food 
 
Grape medium      grape juice 
        1.5 % agar 
        1 % nipagin (20 % in EtOH) 
 
4.4 Fly stocks, genetic background and general animal husbandry 
The wild type stock used was w
Dah 
Wol+, carrying the intracellular bacterium Wolbachia. 
This stock is maintained in large population cages to reduce inbreeding.  All fly lines were 
backcrossed for at least 9 generations into the w
Dah 
background. Backcrossed fly lines were 
kept in bottles (13.5 cm x 6 cm diameter) on standard food in order to maintain them in large 
cohorts. Backups of non-backcrossed stocks were kept in plastic vials (9.5 cm x 2.5 cm 
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diameter). All stocks were kept on a 12:12 light:dark cycle at 18°C and 65% humidity in a 
controlled temperature (CT) room.  
Table 13: Fly stock list. 
Name Genotype source 
wild type wDah Wolbachia + Groenke et al., 2010 
dilp2-3,5  wDah; dilp2-3,5  Groenke et al., 2010 
#6934 y
1
, w*; P{70FLP}11, P{70I-SceI}2B, 
sna
Sco
/CyO, S
2
 
Bloomington Drosophila Stock 
Center  
#766 y1w67c23P{Crey}1b; snaSco/CyO Bloomington Drosophila Stock 
Center  
#3938 w1118; P{70FLP}10 Bloomington Drosophila Stock 
Center  
miR-986KO wDah; miR-986KO Jennifer A. Werner, this study 
miR-986KO* wDah; miR-986KO* Jennifer A. Werner, this study 
UAS-miR-986 w1118; UAS-miR-986 Bejarano et al., 2012 
UAS-miR-210 w1118; UAS-miR-210 Bejarano et al., 2012 
UAS-miR-7 w1118; UAS-miR-7 Bejarano et al., 2012 
UAS-miR-954 w1118; UAS-miR-954 Bejarano et al., 2012 
UAS-miR-978 w1118; UAS-miR-978 Bejarano et al., 2012 
UAS-miR-2500 w1118; UAS-miR-2500 Eric C. Lai, PhD 
UAS-miR-285 w1118; UAS-miR-285 Bejarano et al., 2012 
Tubulin-Gal4 y1 w*; P{tubP-GAL4}LL7/TM3, Sb1 Bloomington Drosophila Stock 
Center  
MHC-Gal4 w*; P{Mhc-RFP.F3-580}2, P{Mhc-
GAL4.F3-580}2/SM6b 
Bloomington Drosophila Stock 
Center  
Tubulin-GS wDah; Tubulin-GeneSwitch Fernandez et al., 2009 
Da-GS wDah; Daughterless-GeneSwitch Tricoire et al., 2009 
S1106-GS w
Dah; S1106-GeneSwitch Roman et al., 2001 
 
4.5 Collecting males and virgins and setting up crosses 
Virgin females were collected in the morning from bottles which were cleared the day before 
and kept at 18 °C over night for a maximum of 16 h to ensure virginity. Parental flies for 
crossings were anesthetized by CO2 and collected. Collected males and females were kept in 
bottles at 25 °C on a 12:12 light:dark cycle and 65 % humidity for 48 h to mate and were then 
transferred into cages with grape plates.    
4.6 Egg collections for experiments 
In order to assure standard larval density for experimental flies, parental flies were kept on 
grape agar plates to allow egg laying for 6 h.  Eggs were washed of the plates with PBS using 
a brush. Eggs were then transferred into falcon tubes and allowed to settle down. PBS 
supernatant was removed and 20 µl eggs were pipetted per bottle using a cut pipette tip.  
Bottles with standardized amount of eggs were kept at 25 °C on a 12:12 light:dark cycle and 
65 % humidity.  
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4.7 Mapping of transgene insertions  
Male flies with unknown transgene insertion site, which contains the mini-white marker, were 
crossed to the female balancer lines CyO/+ and Tm3Sb/+. If all female F1 flies had red eyes 
and male flies had white eyes, the insertion is located on the X-Chromosome. If not, red-eyed 
F1 flies containing the respective balancer were intercrossed. F2 offspring flies were screened 
for red eyes. The insertion was mapped to the second chromosome, if all flies containing CyO 
had red eyes and all flies containing Tm3Sb had white or red eyes. The insertion was mapped 
to the 3rd chromosome if all flies containing Tm3 Sb had red eyes and all flies containing 
CyO had white or red eyes. 
4.8 Expression of genes with the UAS/Gal4 System 
In Drosophila, overexpression of a specific gene can be achieved by the binary Gal4/UAS 
system (Brand and Perrimon, 1993). The method is based on the activation of transcription by 
the yeast transcription activator Gal4 that binds to the upstream activation sequence (UAS) 
fused to sequences of the gene of interest (Figure 2.7 B). Flies expressing Gal4 (driver lines) 
are crossed to flies harbouring the UAS-transgene. F1 flies will express the gene of interest in 
a manner depending on the used Gal4 promoter. Modification of this system allows temporal 
expression induced by RU486 (Osterwalder et al., 2001), which is achieved by a RU486-
dependent GAL4 protein (GeneSwitch). 
4.9. Fly stress assays  
Flies reared at standard density (see chapter 4.6) were allowed to mate after eclosing for 48 h 
in bottles at 25 °C on a 12:12 light:dark cycle and 65 % humidity. Flies were then sorted 
according to gender into plastic vials with SYA food. 5 x 20 flies per vial were used per 
treatment. Flies were transferred into new vials every 2 days, before starting the assay at the 
age of 10 days. For the stress assay flies were transferred into vials containing the stress 
media, which was prepared freshly on the day of the experiment (see chapter 4.3). Dead flies 
were counted in regular time intervals.   
4.10 Lifespan assay 
Experimental flies were reared at standard density (see chapter 4.6) and transferred into new 
bottles after eclosing. After a mating period of 48 h, 10 flies per glass vial (7.5 cm x 2.55 cm 
diameter) with standard SYA food and 20 flies per plastic vial (9.5 cm x 2.5 cm diameter) 
with food containing RU486 were allocated. Flies were transferred into new vials three times 
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a week and kept at 25 °C on a 12:12 light:dark cycle and 65 % humidity. The number of dead 
flies per vial was counted on the day of transfer.  
4.11 Fecundity assay 
The number of eggs laid was counted as readout for fecundity. Lifespan flies at the age of 10 
days were kept on fresh food for 12-16 h and then transferred to new vials. The number of 
eggs laid over this time period was counted for each vial. Data represent cumulative number 
of eggs laid per female.  
4.12 Development time assay 
For measurement of development time parental flies were allowed to lay eggs for 3 h on grape 
plates. Eggs on the plate were kept on 25 °C until first instar larvae hatched. First instar larvae 
were hand-picked and transferred into glass vials at a density of 50 larvae per vial on standard 
food. The number of eclosing adults flies was recorded at regular time points. 
4.13 Body weight 
For body weight measurements, flies were anesthetized on ice and then weighted in pairs on a 
semi-microbalance (ME235S, Sartorius Mechantronics).  
4.14 Tissue dissection 
All tissues were manually dissected using fine forceps on silicone plates with PBS. The brain 
includes the optical lobes and attaching connective tissue as well as residual fat tissue from 
the head. The thorax includes the wings and legs and excludes the gut. Thus the dissected 
thorax mainly consists of muscle tissue. The digestive tract is the midgut excluding 
malpighian tubules. The whole abdomen is dissected, excluding ovaries, digestive tract and 
malpighian tubules. Thus, what is referred to as abdomen consists of the abdominal carcass 
with adhering fat tissue. Tissues were dissected in 1x PBS, snap frozen in tubes on dry ice and 
stored at -80 °C. RNA from dissected tissues was used for next generation sequencing and for 
microarrays.  
4.15 Mechanic separation of thoraces and heads 
Flies were frozen in liquid nitrogen and heads, thorax as well as abdomen were separated by 
vortexing in a reagent tube. First, heads were separated from thorax and abdomen through a 
sieve. Thoraces were then separated from abdomen by intensive vortexing and manual 
selection on dry ice using a fine brush. 
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4.16 General cloning techniques and molecular biology 
4.16.1 Polymerase chain reaction (PCR) 
PCR is a widely common technique used to amplify DNA molecules (Saiki et al., 1988). PCR 
reactions for cloning or genotyping were carried out in a Veriti 96 well thermal cycler 
(Applied Biosystems). Oligonucleotide primers for PCR reactions were purchased from 
MWG-Biotech. For a complete list of oligos used in this study see supplemental table 3. 
 4.16.1.1 Genotyping of flies by PCR 
For genotyping of flies the HotStarTaq Plus DNA Polymerase (Qiagen) was used. 150 ng 
DNA and 0.5 µl of each primer at the concentration of 10 μM were mixed with 10 µl of 
HotStarTaq Plus Master Mix (2x) and water was added to adjust the total volume to 20 µl.  
The cycler was programmed as follows: Step 1  95 °C  5 min  
      Step 2  94 °C  30 sec 
      Step 3  50–68 °C 30 sec 
      Step 4  72 °C  1 min 
      Step 5  72 °C  7 min 
      Step 6  4 °C  ∞ 
Steps 2-4 were repeated 35 times.  
 4.16.1.2 Amplification of cloning constructs 
For the amplification of DNA fragments used for cloning, the Phusion® High-Fidelity DNA 
Polymerase (Thermo Fisher Scientific) was used. 150 ng DNA, 0.4 µl dNTPs (10 mM), 1 µl 
of each primer (10 μM) and 0.2 µl Phusion DNA Polymerase were mixed with 4 µl of 
Phusion HF buffer (5x) and water was added to adjust the total volume to 20 µl. 
The cycler was programmed as follows: Step 1  98 °C  30 sec  
      Step 2  98 °C  10 sec 
      Step 3  50–68 °C 30 sec 
      Step 4  72 °C  30 sec 
      Step 5  72 °C  7 min 
      Step 6  4 °C  ∞ 
Steps 2-4 were repeated 35 times.  
 
 
 
 
Material and methods 
 
78 
 
 4.16.1.3 Quantitative real-time reverse transcription-PCR (qRT-PCR) 
   4.16.1.3.1 qRT-PCR of miRNAs 
qRT-PCR of miRNAs was conducted using the TaqMan® Universal PCR Master Mix No 
AmpErase® UNG (Applied Biosystems). 1.5 µl cDNA was mixed with 7.5 µl H2O, 10 µl 
TaqMan® Mastermix and 1 µl miRNA-specific TaqMan® assay. PCR was done using the 
7900HT Fast Real-Time PCR System (Applied Biosystems). Raw data were analyzed using 
the sequence detection systems software 2.3 (Applied Biosystems). Data were analyzed using 
the ΔΔCt method and normalized to small nucleolar (sno) RNA that was shown to produce 
more reliable results than the 2S rRNA control (Supplemental Figure S5).  
PCR was done using the 7900HT Fast Real-Time PCR System (Applied Biosystems) with 
following program:    Step 1  95 °C  10 min 
      Step 2  95 °C                   15 sec 
      Step 3  60 °C                   1 min 
 
Steps 2 and 3 were repeated 40 times. 
   4.16.1.3.2 qRT-PCR of mRNAs 
qRT-PCR of mRNAs was conducted using the TaqMan® Gene Expression Master Mix 
(Applied Biosystems). 2 µl diluted cDNA (1:1) was mixed with 7 µl H2O, 10 µl TaqMan® 
Gene Expression Master Mix (2x) and 1 µl mRNA-specific TaqMan® Gene Expression 
Assay (20x). The internal Rpl32 control reaction mix consisted of 10 µl TaqMan® Master 
Mix (2x), 0.8 µl Primer SOL268 and SOL269 (10 µM), 0.4 µl FAM-Probe (10 µM) and 6.8 
µl H2O. 
PCR was done using the 7900HT Fast Real-Time PCR System (Applied Biosystems) with 
following program:    Step 1  95 °C  10 min 
      Step 2  95 °C                   15 sec 
      Step 3  60 °C                   1 min 
 
Steps 2 and 3 were repeated 40 times. 
Raw data were analyzed using the sequence detection systems software 2.3 (Applied 
Biosystems). Data were analyzed using the ΔΔCt method and normalized to Rpl32. 
4.16.2 Agarose gel electrophoresis 
DNA fragments of samples were separated by size by agarose gel electrophoresis. A 
molecular weight marker (HyperLadder™ II, Bioline) and samples mixed with DNA loading 
buffer (6x, thermo scientific) were applied on a gel consisting of 0.5 x TAE with 1 % agarose 
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and 0.5 μg/mL EtBr submerged in 0.5 x TAE. DNA fragments were separated by applying 
constant 5 V/cm with 400 mA and 400 W to the tank until adequate separation occurred.  
4.16.3 Gel elution  
In order to recover DNA from agarose gels, the appropriate DNA band was cut out with a 
clean scalpel. The DNA was eluted from the gel piece using the QIAquick
®
 Gel Extraction 
Kit (Qiagen) following the manufacturers instructions. 
4.16.4 cDNA synthesis by reverse transcription of miRNAs 
cDNA from miRNA was produced using the NCode™ VILO™ miRNA cDNA synthesis kit 
(Invitrogen) with miRNA specific TaqMan
®
 primers (Applied biosystems). 5 µl containing 
300 ng RNA was mixed with 0.15 µl dNTPs (100 mM), 1 µl MultiScribe™ Reverse 
Transcriptase, 1.5 µl reverse transcriptase buffer (10 x), 0.19 µl RNase Inhibitor (20 U/µl), 
4.16 µl H2O and 3 µl specific primer. Reverse transcription was conducted using a Veriti 96 
well thermal cycler (Applied Biosystems) with following cycle program:   
16°C  30 min 
42°C  30 min 
85°C  5 min 
4°C  ∞ 
 
4.16.5 cDNA synthesis by reverse transcription of total RNAs 
cDNA from total RNA was produced using the Superscript® VILO™ cDNA synthesis kit 
(Invitrogen). 1 µg total RNA in 14 µl H2O was mixed with 4 µl VILO™ Reaction Mix (5x) 
and 2 µl SuperScript® Enzyme Mix (10x). cDNA was synthesized by incubation at 25 °C for 
10 minutes and incubation at 42 °C for 60 minutes in a thermal cycler. The reaction was 
terminated by incubation at 85 °C for 5 minutes.  
4.16.6 Restriction digest  
For the cleavage of DNA at specific sites, restriction endonucleases from New England 
Biolabs were used. Usually, for analytical restriction 1 µg DNA was cleaved by mixing it 
with 0.5 µl restriction enzyme (5 U) and 2.5 µl appropriate NEB buffer (10x) in a total 
volume of 25 µl. The reaction was incubated for 1 h at an enzyme-dependent temperature. For 
cloning purpose 10 µg DNA were digested.  
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4.16.7 In-Fusion
®
 cloning 
In-Fusion
®
 cloning is a fast method for cloning based on recombination between fragment 
and vector. The In-Fusion
®
 HD Cloning (Clontech Laboratories) was conducted following the 
procedure for Spin-Column Purification of PCR fragments. For the In-Fusion
®
 reaction 
cloning primers for the fragment were designed according the manufacturers protocol and 
used for amplification by PCR. The PCR fragment was purified and the target vector was 
linearized by restriction digest (see 4.16.6). 200 ng PCR fragment was mixed with 200 ng 
vector and 2 µl In-Fusion HD Enzyme Premix (5x) in a total reaction volume of 10 µl. The 
reaction was incubated for 10 minutes at 50 °C, placed on ice and used for transformation of 
chemically competent E. coli. 
4.16.8 Transformation of chemically competent E. coli 
For transformation of chemically competent cells One Shot
®
 TOP10 cells (Invitrogen) were 
used. After thawing frozen cells on ice, 1 µl (50 ng DNA) was added, gently mixed and 
incubated on ice for 30 minutes. Transformation was induced by heat shock for 30 seconds at 
42 °C. Bacteria were placed on ice for two minutes before 250 µl pre-warmed S.O.C medium 
was added. The cells were incubated at 37 °C for 1 h at 225 rpm in a shaking incubator and  
50 µl was spread on pre-warmed selective plates containing the appropriate antibiotic. The 
plates were inverted and incubated overnight at 37 °C. Bacterial colonies were used for 
inoculation of LB media. 
4.16.9 Plasmid DNA purification  
Small amounts of plasmid DNA was purified from 2 ml overnightbacterial cultures, which 
were produced by the inoculation of antibiotics containing LB medium with single colonies at 
37 °C. Bacteria were harvested by centrifugation at room temperature and 8000 rpm for 10 
minutes. For purification of plasmid DNA the QIAprep
®
 Spin Miniprep kit (Qiagen) was used 
according to the protocol of the manufacturer. 
4.16.10 Plasmid DNA purification for generation of transgenic flies 
In order to obtain high quality DNA for injections to generate transgenic fly lines, the 
QIAGEN Plasmid Midi Kit was used according to manufacturers protocols. Single bacterial 
colonies were used to inoculate a starter culture of 2 ml of LB medium with appropriate 
antibiotics. Bacterial cultures were grown for 8 hours at 37 °C and 300 rpm. 50 µl starter 
culture was used to inoculate 100 ml LB medium with appropriate antibiotics which was 
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incubated overnight at 37 °C and 300 rpm. The bacterial cells were harvested by 
centrifugation at 6000 g for 15 min at 4 °C.  
4.16.11 Conventional Sanger sequencing of cloned constructs 
DNA sequencing was done in house by Regina Dirksen on a 3730 DNA Analyzer sequencer 
(Applied Biosystems) at the Max-Planck-Institute for Biology of Aging. 
4.16.12 Genomic DNA preparation from whole flies 
A single fly was placed into a tube and homogenized in 50 µl squishing buffer using a pipette 
tip and incubated at 37 °C for 20 minutes. Proteinase K was inactivated by heating to 95 °C 
for 2 minutes and then the homogenate was briefly centrifuged. 1 µl of the supernatant 
containing the DNA was used for PCR analysis. 
4.16.13 RNA extraction  
Tissues or whole flies were homogenized in 700 µl QIAzol Lysis Reagent using FastPrep™ 
Lysing Matrix tubes and the FastPrep
®
-24 instrument at maximum speed for 20 seconds. 
RNA was extracted using the miRNeasy Mini Kit (Qiagen) following the protocol for 
purification of total RNA including small RNAs, from animal tissues. Purified RNA was 
eluted in 30 µl elution buffer.  
4.16.14 Determination of RNA concentration  
RNA concentration was measured using the Qubit® 2.0 Fluorometer and the Qubit™ RNA 
BR Assay Kits (Invitrogen). Quantification of RNA by the Qubit system is based on a 
comparison with a standard curve generated with kit-included standard concentrations.  
4.16.15 Polyacrylamide RNA gel electrophoresis 
RNA gel electrophoresis was conducted using a PROTEAN
®
 II xi Cell (Bio-Rad) with a 15 % 
polyacrylamide/urea gel in 0.5 x TBE buffer.  The polyacrylamide/urea gel was prepared as 
follows: 18 g urea was dissolved in 14.075 ml acrylamide solution (40 %, 29:1) and 3.75 ml 
TBE (10x) by stirring at 37 °C. 6.33 ml water was added. For polymerization 187.5 µl 
ammonium persulfate (APS; 10 %) and 18.75 µl TEMED was added. The solution was mixed 
and the gel was poured avoiding the introduction of air bubbles. Polymerization was complete 
after 45 minutes. The gel was pre-run at 275 Volt for 30 minutes and remaining non-
polymerized acrylamide was rinsed off the wells using a small pipette tip. Samples were 
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mixed 1:1 with RNA loading dye (2x; 89.75 % Formaldehyde, 10 % TBE (5x), 0.05 % 
sodium dodecyl sulfate (SDS),  0.05 % bromophenol blue) and miRNA marker (NEB) and 
denatured at 95 °C for 2 minutes before loading on the gel. The gel was run at 300 Volt for 
300 minutes with permanent cooling of the buffer by connecting the gel running apparatus to 
a GD120 water bath (Grant). For visualization the gel was incubated in an 1 % EtBr solution 
for 30 minutes and viewed under UV light. The invisible band containing small RNAs was 
cut out at the size between 19 and 26 bases.   
4.16.16 RNA gel elution and precipitation  
The excised polyacrylamide gel containing small RNAs was crushed with a RNA-free pistol 
and RNA was eluted using 528 µl elution buffer (17.96 µl H2O, 2 µl NaOac (3M), 40 µl 
EDTA (0.5 M), 3 µl RNase Inhibitor) with agitation overnight at 4°C.  The sample was 
centrifuged at 4 °C at 10000 rpm and the gel-free supernatant was mixed with 70 µl 3M 
Sodium Acetate pH 5.5, 2 µl GlycoBlue
TM
 and 600 µl isopropanol and placed at -80 °C for 30 
minutes for precipitation. The sample was centrifuged at 4 °C and 20000 g for 30 minutes. 
The supernatant was discarded and the pellet was washed with cold 80 % EtOH. EtOH was 
removed and the RNA pellet was air dried for 5 minutes and then resuspended in 8 µl DEPC-
treated water. 
4.17 Generation of targeting construct and donor flies for the knock-out of     
miR-986  
A targeting construct for homologous recombination was generated by cloning 4 kb upstream 
and 4 kb downstream sequences flanking the miR-986 gene into the targeting vector pW25 
(Gong and Golic, 2004). Upstream flanking sequence was cloned into BsiWI and AscI 
restriction sites with primers 140 and 141 using the In-Fusion
®
 HD Cloning Kit (Clontech). 
Downstream flanking sequence was cloned into SphI and NotI using primer 154 and 155 and 
the In-Fusion
®
 HD Cloning Kit (Clontech). The correct sequence of the vector containing the 
mir-986 flanking sequences was verified by sequencing. The construct was injected by 
BestGene Drosophila Embryo Injection Services (www.thebestgene.com). The insertion of 
resulting donor flies was mapped to the 3rd chromosome. 
4.18 Generation of miR-986
KO 
flies 
In order to generate miR-986
KO
 flies, donor flies with insertion on the 3rd chromosome were 
crossed to flies expressing FLP recombinase and I-SceI endonuclease (y
1
, w*; P{70FLP}11, 
P{70I-SceI}2B, sna
Sco
/CyO, S
2
). The FLP recombinase mobilizes the DNA from the targeting 
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construct and the I-SceI endonuclease linerarizes the extrachromosomal circular DNA to 
enable effective homologous recombination with the endogenous DNA at the target locus. 
Activation of FLP recombinase and I-SceI endonuclease was induced by heatshock of first 
instar larvae at 38 °C for 1h. Putative homologous recombination events were identified by 
the fast screening method (Gong and Golic, 2003). Therefore, mosaic-eyed or white-eyed flies 
were crossed to flies expressing FLP recombinase (w
1118
; P{70FLP}10) and first instar larvae 
were heatshocked at 38 °C for 1 h. Flies were screened for red eyes as marker for targeting 
events. PCR was used for the identification of miR-986
KO
 mutants using primer 185 and 186.  
To generate miR-986
KO*
 flies lacking the mini-white marker gene, which is flanked by loxP-
sites, miR-986
KO
 flies were crossed to flies providing expression of Cre recombinase 
(y
1
w
67c23
P{Crey}1b; sna
Sco
/CyO). First instar larvae were heat-shocked at 38°C for 1 h to 
induce expression of Cre recombinase and the removal of the mini-white gene. Resulting 
mosaic-eyed F1 males were crossed to w; +/CyO virgins. Removal of mini-white gene in 
white-eyed F2 flies was verified by eye color. 
 
4.19 Microarrays 
For microarray analyses 50 thoraces of 10 days old female wild type and 100 thoraces of 
dilp2-3,5 flies were mechanically separated or dissected. Per sample we used 50 wild type and 
100 dilp2-3,5 abdomen or digestive tracts, respectively. 200 brains were used per genotype 
and sample.Total RNA was isolated, labeled with the Genisphere FlashTag® Biotin HSR kit 
and hybridized to Affymetrix GeneChip® miRNA Arrays 1.0 or 2.0 according to the 
protocols of the manufacturer by Dr. Bruno Hüttel at the Max-Planck Institute for plant 
breeding in cologne. Affymetrix GeneChip 1.0 contained probes for 152 and GeneChip 2.0 
contained probes for 186 Drosophila microRNAs. Three biological replicates were used per 
tissue and genotype. 
4.20 RNA column fractionation 
In order to isolate small RNA for sequencing, total RNA was fractionated using the LabChip
®
 
XT by Dr. Bruno Hüttel at the Mack-Planck Institute for plant breeding in cologne.  
4.21 rRNA depletion using magnetic beads 
In order to deplete the most abundant rRNA species in the samples, streptavidin coupled 
Dynabeads
®
 were used. This technique is based on magnetic separation of biotinylated DNA 
oligonucleotides complementary to the target rRNA sequence of the input RNA.  The rRNA-
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complementary oligonucleotide was used at a final concentration of 2 pM/µl and had the 
sequence: 5'BIO-TGCTTGGACTACATATGGTTGAGGGTTGTAA-3' A6T. Total RNA or 
gel-isolated small RNA was mixed with DEPC-treated water in a non-stick microfuge tube to 
a total volume of 21 µl. 5 µl rRNA-complementary oligonucleotide and 3 µl 20 x SSC was 
added. The mixture was incubated for 2 minutes at 70 °C and then put on ice. 1 µl 
SUPERaseIn
TM
 was added and the mixture was incubated for 15 minutes at 37 °C with 
shaking at 400 rpm in an Eppendorf thermomixer. The sample was chilled on ice for 5 
minutes. In the meantime, 150 µl vortexed MyOne Streptavidin C1 dynabeads were prepared 
by washing 3 times in 150 µl 1 x MyOne C1 dynabead B&W buffer + 0.01 % Tween, 2 times 
in 150 µl solution A and 2 times in 150 µl solution B. The beads were resuspended in 30 µl   
2 x MyOne C1 dynabead B&W buffer + 0.01 % Tween. The sample was briefly centrifuged 
and added to the beads. Target rRNA bound to the antisense oligonucleotides by incubation 
for 15 minutes at room temperature with gentle agitation at 400 rpm. To remove the beads the 
tube was placed on a magnetic stand and the supernatant was transferred into a new non-stick 
tube. The depleted RNA was precipitated by mixing with 468 µl DEPC-treated water, 70 µl 
3M Sodium Acetate pH 5.5, 2 µl GlycoBlue
TM
 and 600 µl isopropanol and placing it at -80 °C 
for 30 minutes. The tube was centrifuged at 4 °C at 20000 g for 30 minutes, the supernatant 
was discarded and the pellet was washed with cold 80 %  EtOH. EtOH was removed and the 
RNA pellet was air dried for 5 minutes and then resuspended in 8 µl DEPC-treated water. 
4.22 Illumina small RNA library preparation 
Small RNA sequencing libraries were generated using the Small RNA v1.5 Kit from Illumina 
following the manufacturers protocol. Small RNA was isolated from 2 µg total RNA and used 
as input for the library. In brief, adapters for reverse transcription and amplification were 
ligated on both ends of the small RNA fragments. The adapter-ligated RNA was reverse 
transcribed and then amplified. The cDNA was further gel-purified to exclude adapter dimer 
sequences in the library.  
4.23 Cluster generation and sequencing 
Cluster generation and 100 bp single read next generation sequencing was done using the 
Illumina HiSeq2500 sequencer by Dr. Bruno Hüttel at the Mack-Planck Institute for plant 
breeding in cologne.  
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4.24 Data analysis 
4.24.1 Statistics 
Lifespan data were subjected to survival analysis by Log-rank test (Peto and Peto, 1972) using 
Excel software. Unless otherwise noted, following statistic tests were used: Fecundity was 
tested by Wilcoxon rank test. Single qRT-PCR data was analyzed using Student's t-test. In 
order to analyze differences between groups, analysis of variance (ANOVA) was used and 
groups with significant differences were identified using Tukey-Kramer post-hoc analysis. 
Statistical analysis of microarray data is described in chapter 4.24.4.6 and statistical analysis 
of sequencing data is described in chapter 4.24.5.  
4.24.2 Calculation of melting temperature (Tm) 
Melting temperature of miRNAs was calculated with the formula: Tm= 0.41 x (%GC-
content)+69.3-(650/sequence length). 
4.24.3 Calculation of tissue specificity score 
The specificity score evaluates the tissue specificity of the expression of a specific miRNA 
and is calculated as described in Landgraf et al. (Landgraf  et al., 2007): 
Specificity scorem = log2(number of tissue types) + Σt Gm,t log2(Gm,t)     
Gm,t = Fm,t / Σt' Fm,t'. Fm,t = normalized count; t= tissue type; m = miRNA; t' = other tissue 
types; m' = other miRNAs. Only microRNAs with reads >10 or chip expression >15 in wt and 
dilp2-3,5 flies were used for analysis of tissue-specificity. 
4.24.4 Computational miRNA target prediction  
MiRNA targets were predicted using the miRanda algorithm (Enright et al., 2003) and rated 
using SVR score (Betel et al., 2010) of the online miRNA.org source (for details see chapter 
2.3.2).  
4.24.5 Data analysis of microarray data  
  4.24.5.1 Preprocessing 
Microarray data preprocessing was conducted by Affymetrix

  miRNA QC tool and included 
image analysis, background adjustment, normalization and summarization.  
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  4.24.5.2 Image analysis 
Probe sets consisting of perfect match probes and mismatch probes were used to estimate the 
microRNA signal intensity. The intensity of a signal detection call was determined by the 
Wilcoxon Rank-Sum test of the probe set signals compared to the signals from GC content 
matched anti-genomic probes. Probes with p-values > 0.06 were counted as „not detected“ 
above background. Fischer’s exact test is used for computing the probe set p-value. 
  4.24.5.3 Background adjustment 
GC content matched background signals were determined by the same set of anti-genomic 
probes used for signal detection calls. The background was subtracted from each miRNA 
probe signal value. 
  4.24.5.4 Normalization 
Measurements across microarrays can vary due to differences in reagent batches, sample 
preparation, hybridization, in physical differences of the arrays or differences in scanning. To 
allow inter-array comparisons of probe intensities, the Affymetrix® miRNA QC tool uses 
quantile normalization (Boldstad et al., 2003). This normalization method forces the data to 
have the same distribution of log(probe intensities). 
  4.24.5.5 Summarization 
To obtain one value from a set of probes for each miRNA, the Affymetrix
®
 miRNA QC tool 
uses median polish. This summarization method ignores outlier probe-level values (Irizarry et 
al., 2003). 
Data preprocessing by the Affymetrix
®
 miRNA QC tool gives rise to a miRNA expression 
matrix with expression values in rows and arrays in columns. These data were used for further 
analyses. Probe sets of microRNAs that were not called „present“ by detection call in 2 of 3 
samples in one tissue group were assessed as „not detected“.  
  4.24.5.6 Statistics 
Statistical significance of miRNA expression fold changes in dilp2-3,5 flies by microarray 
were evaluated by Student's t-test. P-values of multiple comparisons were adjusted by the 
Benjamini Hochberg procedure (Benjamini and Hochberg, 1995). 
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4.24.6 Analysis of sequencing data 
For the analysis, adapter sequences were computationally clipped from the raw sequencing 
data. MiRNAs in the sequencing datasets were identified using the algorithm miRDeep 
(Friedländer et al., 2008). This algorithm aligns reads to the genome and decides whether a 
plausible miRNA precursor is formed. It then scores the probability for a predicted precursor 
to be a real miRNA precursor.  
MiRDeep aligns mature Drosophila miRNA sequences to the sequencing reads and allows for 
mismatches in the last three nucleotides of the mature sequences. At the end the algorithm 
counts the number of reads mapping to a miRNA. In order to compare different libraries, read 
counts were normalized to total read number. 
To identify the source of the reads that did not map to Drosophila miRNAs the dataset was 
aligned to the genome of Wolbachia pipientis (NC_002978.6), the genome of Saccharomyces 
cerevisiae and to Drosophila 18s-2s-5s-28s rRNA by BLAST.  
4.24.7 Computational identification of differentially expressed miRNAs 
Differential expressed miRNAs were identified using the "R"-package DESeq, which 
provides methods to test for differential expression (Anders and Huber, 2010). 
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5 Supplements 
5.1 Supplemental Figures 
 
Figure S1: Differential expression of miR-2500-5p in tissues of different insulin mutants and at two 
SYA food concentrations. Significant downregulation was detected by qRT-PCR in different samples 
as indicated by asterisks. miRNA transcript level was normalized to wild type samples, which by 
default was set to 1.* p<0.05; ** p<0.01, Student'st-test. 
 
 
Figure S2: Overexpression of miR-285 was not detected. qRT-PCR analysis reveals no upregulation 
of miR-285. miRNA transcript level was normalized to tubulinGS/+ with RU, which by default was set 
to 1.* p<0.05; ** p<0.01, Student'st-test  
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Figure S3: Tissue specificity of miRNA expression in dilp2-3,5 flies as detected by next-generation 
sequencing. Tissue specificity of several miRNAs differs in dilp2-3,5 flies. The total height of each bar 
represents the tissue specificity and the relative heights for each of the tissues are proportional to 
miRNA expression in a given tissue type relative to all tissue types. miRNAs with at least 10 reads 
are included in the analysis. 
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Figure S4: Comparison of dilp2-3,5 absolute expression data as detected by microarrays and next 
generation sequencing. dilp2-3,5 absolute expression data are similar to wild type data. (A) 
Comparison of expression data in brain, thorax, digestive tract and abdomen as detected by 
microarray hybridized with total RNA and sequencing of libraries generated from isolated small RNA. 
Pearson correlation coefficient of fold change data was computed. (B) Comparison of expression of 
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sequencing datasets and datasets from microarrays hybridized with the same isolated RNA as used 
for sequencing. Using the same RNA for both platforms does not increase correlation. (C) Comparison 
of datasets from microarrays hybridized with total RNA and isolated RNA show strong correlation. 
 
 
Figure S5: Comparison of performance of the internal miRNA controls 2S rRNA and sno RNA. The 
usage of sno RNA leads to a better significance of results due to more suitable Ct values for the raw 
data analysis via the ΔΔCt method. miRNA transcript level was normalized to tubulin-Gal4 samples, 
which by default was set to 1. ** p<0.01; *** p<0.001, Student's t-test 
 
5.2 Supplemental Tables 
microRNA conservation level sequencing reads (pooled tissues) 
dme-mir-276a 4 1607779.82 
dme-mir-1 5 1059892.77 
dme-mir-8 5 898535.04 
dme-bantam 5 662351.58 
dme-mir-184 5 409008.16 
dme-mir-10 5 401430.01 
dme-mir-14 3 332219.85 
dme-mir-34 5 322346.89 
dme-mir-263a 5 285094.50 
dme-mir-276b 4 222985.93 
dme-mir-956 1 209390.08 
dme-mir-277 3 175067.85 
dme-let-7 5 145879.60 
dme-mir-999 3 136730.78 
dme-mir-7 5 106241.11 
dme-mir-305 4 98811.07 
dme-mir-283 5 90028.42 
dme-mir-375 5 67902.49 
dme-mir-9a 5 67606.33 
dme-mir-11 3 63844.16 
dme-mir-31a 5 42876.11 
dme-mir-317 4 41535.06 
dme-mir-957 3 39215.73 
dme-mir-33 5 32028.52 
dme-mir-281-2 5 30571.98 
dme-mir-9b 5 28122.78 
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dme-mir-190 5 27088.38 
dme-mir-275 4 26223.56 
dme-mir-281-1 5 26089.99 
dme-mir-958 2 25061.65 
dme-mir-987 2 21260.57 
dme-mir-9c 5 19220.19 
dme-mir-100 5 17301.80 
dme-mir-314 2 17051.61 
dme-mir-986 2 16809.10 
dme-mir-252 5 16420.49 
dme-mir-278 5 16409.36 
dme-mir-125 5 15634.15 
dme-mir-284 2 12932.56 
dme-mir-263b 5 12017.82 
dme-mir-927 3 10399.92 
dme-mir-315 5 9194.69 
dme-mir-133 5 8663.25 
dme-mir-13b-2 5 7615.46 
dme-mir-13b-1 5 7530.33 
dme-mir-12 5 7153.42 
dme-mir-2b-2 5 6784.09 
dme-mir-981 5 6722.11 
dme-mir-1012 2 6701.53 
dme-mir-279 5 5883.85 
dme-mir-306 3 5359.71 
dme-mir-932 3 4566.55 
dme-mir-993 5 4378.74 
dme-mir-988 3 4175.03 
dme-mir-2b-1 5 4139.65 
dme-mir-2a-2 5 4060.51 
dme-mir-137 5 3861.05 
dme-mir-274 2 3772.99 
dme-mir-2a-1 5 3458.05 
dme-mir-318 2 3231.93 
dme-mir-316 3 2843.58 
dme-mir-304 2 2502.21 
dme-mir-970 3 2224.68 
dme-mir-1010 2 2087.70 
dme-mir-989 3 1999.94 
dme-mir-996 3 1752.74 
dme-mir-994 2 1709.17 
dme-mir-965 4 1591.64 
dme-mir-1000 3 1372.23 
dme-mir-998 3 998.46 
dme-mir-210 5 993.74 
dme-mir-929 3 965.99 
dme-mir-92a 5 864.41 
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dme-mir-6-3 2 760.97 
dme-mir-6-1 2 750.12 
dme-mir-6-2 2 749.79 
dme-mir-31b 5 637.20 
dme-mir-87 5 636.43 
dme-mir-995 2 581.18 
dme-mir-1015 1 571.72 
dme-mir-124 5 559.56 
dme-mir-1006 2 553.85 
dme-mir-219 5 553.18 
dme-mir-92b 5 517.46 
dme-mir-2535b 1 487.41 
dme-mir-2c 5 453.23 
dme-mir-5 2 413.76 
dme-mir-1017 1 387.60 
dme-mir-1013 2 373.90 
dme-mir-1001 2 367.14 
dme-mir-286 3 354.41 
dme-mir-307a 5 320.42 
dme-mir-312 2 304.65 
dme-mir-966 1 266.72 
dme-mir-13a 5 256.12 
dme-mir-iab-4 4 221.54 
dme-mir-4951 1 214.89 
dme-mir-2279 1 193.69 
dme-mir-990 1 135.89 
dme-mir-971 3 123.35 
dme-mir-282 3 116.27 
dme-mir-980 3 113.70 
dme-mir-969 2 108.13 
dme-mir-79 5 107.42 
dme-mir-311 2 106.14 
dme-mir-1003 2 98.82 
dme-mir-4 2 65.00 
dme-mir-1004 1 64.33 
dme-mir-954 1 59.97 
dme-mir-310 2 54.37 
dme-mir-4984 1 51.48 
dme-mir-2494 2 50.22 
dme-mir-4969 1 48.00 
dme-mir-4975 1 38.00 
dme-mir-3 3 36.15 
dme-mir-1007 1 35.79 
dme-mir-308 3 35.39 
dme-mir-4911 1 27.77 
dme-mir-955 2 27.30 
dme-mir-967 2 27.19 
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dme-mir-1009 1 26.22 
dme-mir-1002 2 22.00 
dme-mir-4976 1 20.12 
dme-mir-1014 1 18.73 
dme-mir-4960 1 17.90 
dme-mir-984 1 16.80 
dme-mir-193 5 16.33 
dme-mir-983-1 2 14.69 
dme-mir-983-2 2 14.69 
dme-mir-1016 1 13.45 
dme-mir-2500 1 13.10 
dme-mir-982 2 12.00 
dme-mir-4963 1 11.75 
dme-mir-313 2 11.66 
dme-mir-4952 1 10.78 
dme-mir-285 5 9.25 
dme-mir-4958 1 9.23 
dme-mir-1011 2 8.99 
dme-mir-4916 1 8.89 
dme-mir-4973 1 6.85 
dme-mir-4940 1 6.72 
dme-mir-4956 1 5.85 
dme-mir-964 2 5.58 
dme-mir-2489 2 4.76 
dme-mir-4962 1 4.48 
dme-mir-3645 1 4.36 
dme-mir-991 2 4.15 
dme-mir-1005 2 4.02 
dme-mir-960 2 3.47 
dme-mir-4949 1 3.28 
dme-mir-3642 1 3.12 
dme-mir-4961 1 3.12 
dme-mir-976 2 2.93 
dme-mir-2282 1 2.90 
dme-mir-962 2 2.58 
dme-mir-2501 1 2.53 
dme-mir-2283 1 2.44 
dme-mir-4964 1 2.28 
dme-mir-961 2 2.20 
dme-mir-4955 1 2.18 
dme-mir-4944 1 2.16 
dme-mir-974 1 2.14 
dme-mir-3641 1 2.10 
dme-mir-973 1 1.98 
dme-mir-4983 1 1.92 
dme-mir-4953 1 1.84 
dme-mir-4945 1 1.77 
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dme-mir-289 2 1.74 
dme-mir-4957 1 1.64 
dme-mir-959 2 1.63 
dme-mir-4943 1 1.58 
dme-mir-4972 1 1.57 
dme-mir-2492 1 1.46 
dme-mir-979 1 1.39 
dme-mir-968 2 1.31 
dme-mir-975 2 1.30 
dme-mir-iab-8 3 1.27 
dme-mir-963 2 1.20 
dme-mir-4948 1 1.17 
dme-mir-4985 1 1.16 
dme-mir-4913 1 1.04 
dme-mir-4987 1 0.98 
dme-mir-4950 1 0.83 
dme-mir-4982 1 0.82 
dme-mir-4968 1 0.81 
dme-mir-4966 1 0.79 
dme-mir-4915 1 0.75 
dme-mir-4977 1 0.74 
dme-mir-4942 1 0.72 
dme-mir-4910 1 0.71 
dme-mir-309 3 0.67 
dme-mir-4979 1 0.63 
dme-mir-4965 1 0.55 
dme-mir-4939 1 0.53 
dme-mir-977 2 0.48 
dme-mir-972 1 0.47 
dme-mir-2498 1 0.46 
dme-mir-978 2 0.43 
dme-mir-4971 1 0.41 
dme-mir-4978 1 0.35 
dme-mir-4981 1 0.32 
dme-mir-1008 1 0.31 
dme-mir-4974 1 0.27 
dme-mir-2496 1 0.23 
dme-mir-2497 1 0.20 
dme-mir-4912 1 0.20 
dme-mir-4967 1 0.18 
dme-mir-3644 1 0.16 
dme-mir-303 2 0.15 
dme-mir-307b 2 0.14 
dme-mir-2499 1 0.13 
dme-mir-2281 1 0.13 
dme-mir-985 1 0.13 
dme-mir-4980 1 0.12 
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dme-mir-2491 1 0.10 
dme-mir-4941 1 0.10 
dme-mir-4919 1 0.09 
dme-mir-4917 1 0.07 
dme-mir-2495 1 0.05 
dme-mir-3643 1 0.05 
dme-mir-4954 1 0.05 
dme-mir-4947 1 0.04 
dme-mir-997 1 0.03 
dme-mir-2280 1 0.03 
dme-mir-4970 1 0.02 
dme-mir-2490 1 0.00 
dme-mir-2493 1 0.00 
dme-mir-280 2 0.00 
dme-mir-287 2 0.00 
dme-mir-288 2 0.00 
dme-mir-4908 1 0.00 
dme-mir-4909 1 0.00 
dme-mir-4914 1 0.00 
dme-mir-4918 1 0.00 
dme-mir-4946 1 0.00 
dme-mir-4959 1 0.00 
dme-mir-4986 1 0.00 
dme-mir-992 2 0.00 
Supplemental table 1: Phylogenetic conservation and expression level of miRNAs as determined by 
sequencing reads. Conservation level code: 1, Drosophila melanogaster (species); 2, Drosophilidae 
(family); 3, Insecta (class), 4, Ecdysozoa (superphylum); 5, Bilateria. 
 
miRNA calculated melting temperature 
dme-miR-1014-3p 48.11 
dme-miR-2279-5p 49.07 
dme-miR-1006-3p 49.95 
dme-miR-283-5p 50.06 
dme-miR-2279-3p 50.94 
dme-miR-2280-5p 50.94 
dme-miR-2489-3p 50.94 
dme-miR-958-3p 50.94 
dme-miR-983-5p 50.94 
dme-miR-991-3p 50.94 
dme-miR-1009-3p 51.73 
dme-miR-2283-5p 51.73 
dme-miR-304-5p 51.73 
dme-miR-1008-3p 52.01 
dme-miR-4-3p 52.01 
dme-miR-977-3p 52.01 
dme-miR-1003-3p 52.80 
dme-miR-1007-3p 52.80 
dme-miR-2280-3p 52.80 
dme-miR-2282-3p 52.80 
dme-miR-2497-3p 52.80 
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dme-miR-375-3p 52.80 
dme-miR-79-3p 52.80 
dme-miR-972-3p 52.80 
dme-miR-976-3p 52.80 
dme-miR-iab-8-3p 52.80 
dme-miR-1013-3p 53.20 
dme-bantam-3p 53.52 
dme-miR-2501-3p 53.52 
dme-miR-288-3p 53.52 
dme-miR-982-5p 53.52 
dme-let-7-5p 53.97 
dme-miR-1005-3p 53.97 
dme-miR-14-3p 53.97 
dme-miR-2281-3p 53.97 
dme-miR-287-3p 53.97 
dme-miR-87-3p 53.97 
dme-miR-969-5p 53.97 
dme-miR-190-5p 54.18 
dme-miR-2498-5p 54.18 
dme-miR-987-5p 54.18 
dme-miR-137-3p 54.66 
dme-miR-13a-3p 54.66 
dme-miR-1-3p 54.66 
dme-miR-279-3p 54.66 
dme-miR-308-3p 54.66 
dme-miR-315-5p 54.66 
dme-miR-6-3p 54.66 
dme-miR-927-5p 54.66 
dme-miR-961-5p 54.66 
dme-miR-964-5p 54.66 
dme-miR-971-3p 54.66 
dme-miR-974-5p 54.66 
dme-miR-999-3p 54.66 
dme-miR-9c-5p 54.66 
dme-miR-iab-4-5p 54.66 
dme-miR-1012-3p 55.30 
dme-miR-2492-3p 55.30 
dme-miR-7-5p 55.30 
dme-miR-8-3p 55.30 
dme-miR-975-5p 55.30 
dme-miR-984-5p 55.30 
dme-miR-9a-5p 55.30 
dme-miR-9b-5p 55.30 
dme-miR-280-5p 55.86 
dme-miR-963-5p 55.88 
dme-miR-968-5p 55.88 
dme-miR-1000-5p 55.92 
dme-miR-1016-3p 55.92 
dme-miR-314-3p 55.92 
dme-miR-2497-5p 56.42 
dme-miR-10-5p 56.53 
dme-miR-13b-3p 56.53 
dme-miR-276b-3p 56.53 
dme-miR-306-5p 56.53 
dme-miR-318-3p 56.53 
dme-miR-959-3p 56.53 
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dme-miR-960-5p 56.53 
dme-miR-965-3p 56.53 
dme-miR-992-3p 56.53 
dme-miR-994-5p 56.53 
dme-miR-996-3p 56.53 
dme-miR-10-3p 57.08 
dme-miR-12-5p 57.08 
dme-miR-219-5p 57.08 
dme-miR-277-3p 57.08 
dme-miR-281-3p 57.08 
dme-miR-303-5p 57.08 
dme-miR-5-5p 57.08 
dme-miR-956-3p 57.08 
dme-miR-iab-8-5p 57.08 
dme-miR-307-3p 57.30 
dme-miR-1001-5p 57.87 
dme-miR-11-3p 57.87 
dme-miR-2494-5p 57.87 
dme-miR-33-5p 57.87 
dme-miR-970-3p 57.87 
dme-miR-979-3p 57.87 
dme-miR-989-3p 57.87 
dme-miR-995-3p 57.87 
dme-miR-997-5p 57.87 
dme-miR-998-3p 57.87 
dme-miR-2500-5p 58.06 
dme-miR-962-5p 58.06 
dme-miR-100-5p 58.39 
dme-miR-276a-3p 58.39 
dme-miR-285-3p 58.39 
dme-miR-309-3p 58.39 
dme-miR-313-3p 58.39 
dme-miR-932-5p 58.39 
dme-miR-986-5p 58.39 
dme-miR-1011-3p 58.87 
dme-miR-2281-5p 58.87 
dme-miR-2490-5p 58.87 
dme-miR-2498-3p 58.87 
dme-miR-305-5p 58.87 
dme-miR-1002-5p 59.30 
dme-miR-1010-3p 59.30 
dme-miR-2494-3p 59.30 
dme-miR-263a-3p 59.30 
dme-miR-iab-4-3p 59.30 
dme-miR-973-5p 59.70 
dme-miR-263b-3p 59.82 
dme-miR-929-3p 59.82 
dme-miR-954-5p 59.82 
dme-miR-967-5p 59.82 
dme-miR-990-5p 59.82 
dme-miR-289-5p 60.07 
dme-miR-1004-3p 60.25 
dme-miR-125-5p 60.25 
dme-miR-193-3p 60.25 
dme-miR-2495-5p 60.25 
dme-miR-2500-3p 60.25 
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dme-miR-281-2-5p 60.25 
dme-miR-307-as-5p 60.25 
dme-miR-310-3p 60.25 
dme-miR-311-3p 60.25 
dme-miR-312-3p 60.25 
dme-miR-316-5p 60.25 
dme-miR-31b-5p 60.25 
dme-miR-3-3p 60.25 
dme-miR-957-3p 60.25 
dme-miR-978-3p 60.25 
dme-miR-980-3p 60.25 
dme-miR-981-3p 60.25 
dme-miR-985-3p 60.25 
dme-miR-1017-3p 60.65 
dme-miR-2a-3p 60.65 
dme-miR-993-3p 60.65 
dme-miR-274-5p 61.65 
dme-miR-184-5p 61.78 
dme-miR-210-3p 61.78 
dme-miR-2493-5p 61.78 
dme-miR-1015-3p 62.12 
dme-miR-133-3p 62.12 
dme-miR-184-3p 62.12 
dme-miR-2491-5p 62.12 
dme-miR-252-5p 62.12 
dme-miR-278-3p 62.12 
dme-miR-281-1-5p 62.12 
dme-miR-307-as-3p 62.12 
dme-miR-92a-3p 62.12 
dme-miR-276-5p 62.43 
dme-miR-286-3p 62.43 
dme-miR-2b-3p 62.43 
dme-miR-2c-3p 62.43 
dme-miR-31a-5p 62.43 
dme-miR-955-5p 62.43 
dme-miR-2499-5p 62.72 
dme-miR-2501-5p 62.72 
dme-miR-317-3p 62.72 
dme-miR-282-5p 63.66 
dme-miR-966-5p 63.73 
dme-miR-284-3p 63.85 
dme-miR-92b-3p 63.98 
dme-miR-988-3p 63.98 
dme-miR-995-5p 63.98 
dme-miR-124-3p 64.21 
dme-miR-2493-3p 64.21 
dme-miR-34-5p 64.43 
dme-miR-2496-3p 65.85 
dme-miR-275-3p 66.00 
dme-miR-2495-3p 66.13 
dme-miR-2496-5p 66.13 
dme-miR-306-3p 67.71 
dme-miR-2499-3p 67.84 
Supplemental table 2: Calculated melting temperatures for miRNAs. For calculation see chapter 
4.24.1 
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Internal 
primer 
name Sequence Description 
JW109 
ACTGGTGAGGAGGCCAT 
Sequencing miR-986 construct 
upstream sequence 
JW110 
CCATATTGAAATGGAACCCCAG 
Sequencing miR-986 construct 
upstream sequence 
JW111 
CGCAATGCCGCACAG 
Sequencing miR-986 construct 
upstream sequence 
JW112 
TTATACTTACCAGACGATCATGAC 
Sequencing miR-986 construct 
upstream sequence 
JW113 
GTCATGATGCAGAGACAATGTAA 
Sequencing miR-986 construct 
upstream sequence 
JW114 
TTGCTGCCATAAAACAATATATACTGG 
Sequencing miR-986 construct 
upstream sequence 
JW115 
AGCGACTTTACGACCGG 
Sequencing miR-986 construct 
downstream sequence 
JW116 
GATCACCCCAGCATTCCAC 
Sequencing miR-986 construct 
downstream sequence 
JW117 
GATACTACCACTTCTGGAGTGTC 
Sequencing miR-986 construct 
downstream sequence 
JW118 
TCTGGATGAGCTCGTCTCTAA 
Sequencing miR-986 construct 
downstream sequence 
JW119 
CTCAAATCCGATTTACTCGCTG 
Sequencing miR-986 construct 
downstream sequence 
JW120 
TGTGACATGTTAATAACGCTAAGG 
Sequencing miR-986 construct 
downstream sequence 
JW121 
ACTTTGCTCCTGAATATCCAGAA 
Sequencing miR-986 construct 
downstream sequence 
JW140 TCCCTAGGGGATCACGTACGGATGCA
GCAGGCCTCGAC 
miR-986 Infusion cloning 
forward primer of upstream 4 kb 
JW141 CTAGTCTAGGGCGCGCCTCCTCTGC
GTGGCTAACG 
miR-986 Infusion cloning 
reverse primer of upstream 4 kb 
JW154 
TAGTCTAGGGTACCGCATGCAGCGAC
TTTACGACCGGA 
miR-986 Infusion cloning 
forward primer of downstream 4 
kb 
JW155 
AGGGTAATGTACCGCGGCCGCACGT
TGCGCCTCCTTTATAAAC 
miR-986 Infusion cloning 
reverse primer of downstream 4 
kb 
JW185 GCAAGTCATGCTGAAAGCAC miR-986KO genotyping primer 
JW186 CAGTCACAACGCTATTCGAG miR-986KO genotyping primer 
rRNA 
depletion 
oligo 
5'BIOTIN-TGCTTGGACTA 
CATATGGTTGAGGGTTGTAA-3' A6T 
Primer for rRNA oligo depletion 
Supplemental table 3: List of oligonucleotides. 
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